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ABSTRACT
With prolonged lives thanks to antiretroviral therapy, parents living with HIV
(PLH) face challenges regarding telling their HIV-positive status to children (i.e.,
parental HIV disclosure). With aims to assist PLH in making a well-planned and
developmentally appropriate HIV disclosure to their uninfected children, a theory-driven
intervention was conducted among 791 PLH with children aged between 6-15 years in
Guangxi, China.
Guided by the stage model of the Health Action Process Approach (HAPA), three
critical disclosure stages were defined: 1) the pre-intention stage, in which people have
not yet decided to disclose; 2) the intention stage, in which people have decided to
disclose but have not yet started action; 3) the action stage, in which individuals make
actual disclosure event. Accordingly, people at the three stages were defined as preintenders, intenders, and actors.
Using secondary data from the baseline (W1) and the first two follow-ups (W2 at
6-month and W3 at 12-month) data, this dissertation evaluated the intervention effect on
parental HIV disclosure stages and examined the roles disclosure-related psychosocial
factors play in the process. Three major research questions were addressed: 1) is there
any intervention effect on HIV disclosure stage transition between W2 and W3? 2) is
there any intervention effect on disclosure-related psychosocial factors from W1 to W2
and from W2 to W3? 3) do disclosure-related psychosocial factors at W2 yield stagespecific predictive effects on disclosure stage transition from W2 to W3?
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To address the first question, a multigroup first-order manifest Markov Chain
method was conducted to assess intervention effect on disclosure stage transitions
between W2 and W3. Among pre-intenders at the first follow-up, those in the
intervention group were more likely to progress to the action stage rather than being static
(OR = 3.43, 95% CI 1.17, 10.01). However, no statistically significant intervention effect
was detected in promoting progression from pre-intention to intention (OR = 1.02, 95%
CI 0.47, 2.20). Among intenders at the first follow-up, no statistically significant
intervention effect was detected in preventing backward transition to pre-intention (OR =
0.71, 95% CI 0.35, 1.43) or promoting forward transition to action (OR = 2.01, 95% CI
0.84, 4.79).
To address the rest two questions, a proportional latent change score (LCS)
method was used to assess intervention effect on disclosure-related psychosocial factors
including knowledge, outcome expectancy (perceived costs and rewards), self-efficacy,
and planning. Predictive effects of these psychosocial factors on disclosure stage
transitions were examined by treating these factors as covariate in the Markov chain. At
the first follow-up, statistically significant intervention effect was detected for disclosure
knowledge, action self-efficacy, and action planning but not for disclosure outcome
expectancy. Stage-specific predictive effects of action self-efficacy and action planning
on HIV disclosure stage transitions were detected.
Findings from the dissertation have significant implications for future studies.
First, the 3-stage HAPA model can be applied to the evaluation of HIV disclosure
interventions. Second, the identification of stage-specific psychosocial predictors of stage
transition allows the development of stage-matched interventions tailored to their needs.

vii

TABLE OF CONTENTS
DEDICATION ................................................................................................................... iii
ACKNOWLEDGEMENT ................................................................................................. iv
ABSTRACT....................................................................................................................... vi
LIST OF TABLES ............................................................................................................. xi
LIST OF FIGURES .......................................................................................................... xii
CHAPTER 1 INTRODUCTION ........................................................................................ 1
1.1 HIV epidemic ........................................................................................................... 1
1.2 Definition of HIV disclosure.................................................................................... 3
1.3 Outcomes of HIV disclosure .................................................................................... 4
1.4 Psychosocial factors influencing disclosure decision-making ................................. 5
1.5 Children in terms of HIV disclosure ........................................................................ 6
1.6 Parental HIV disclosure ........................................................................................... 7
1.7 Stage models to fill the intention-behavior gap ....................................................... 9
1.8 Research gaps in program evaluation .................................................................... 10
1.9 Aims of the dissertation study................................................................................ 11
CHAPTER 2 BACKGROUND AND SIGNIFICANCE.................................................. 13
2.1 Problem statement .................................................................................................. 13
2.2 Theoretical models of parental HIV disclosure interventions ............................... 14
2.3 Psychosocial factors influencing HIV disclosure .................................................. 16
2.4 Parental HIV disclosure intervention programs ..................................................... 17
2.5 Methodological gaps in evaluation of parental HIV disclosure interventions ....... 20

viii

2.6 Health Action Process Approach ........................................................................... 21
2.7 Conceptual framework ........................................................................................... 23
2.8 Purpose ................................................................................................................... 24
2.9 Research questions ................................................................................................. 25
CHAPTER 3 METHODOLOGY ..................................................................................... 28
3.1 Study setting ........................................................................................................... 28
3.2 Study sample .......................................................................................................... 29
3.3 Intervention delivery .............................................................................................. 30
3.4 Data collection ....................................................................................................... 30
3.5 Intervention contents .............................................................................................. 30
3.6 Key measures ......................................................................................................... 31
3.7 Analysis plan .......................................................................................................... 33
CHAPTER 4 MANUSCRIPTS ........................................................................................ 40
4.1 Intervention Effects of A Theory-based Parental HIV Disclosure Intervention
among Parents Living with HIV (PLH) in China --- Application of the Health Action
Process Approach (HAPA) .......................................................................................... 40
4.2 Psychosocial Factors Predicting Transitions in HIV Disclosure Stages --Evaluation of A Theory-based Parental HIV Disclosure Intervention among Parents
Living with HIV in China ............................................................................................ 60
CHAPTER 5 DISCUSSION AND CONCLUSION ........................................................ 81
5.1 Summary of the dissertation study ......................................................................... 81
5.2 Interpretation of study findings .............................................................................. 82
5.3 Limitations ............................................................................................................. 83
5.4 Implications ............................................................................................................ 84
5.5 Future directions .................................................................................................... 85
5.6 Conclusion ............................................................................................................. 88
REFERENCE.................................................................................................................... 89
ix

APPENDIX A SENSITIVITY ANALYSIS ..................................................................... 97
APPENDIX B MPLUS CODES..................................................................................... 101

x

LIST OF TABLES
Table 3.1 Illustration of the effect size of intervention on transitions .............................. 36
Table 4.1 Baseline characteristics by intervention status ................................................. 52
Table 4.2 Distribution of HIV disclosure stage at W2 and W3 by intervention group .... 53
Table 4.3 Model fit comparing the unrestrained Model 1 with the restrained Model 2 ... 54
Table 4.4 Intervention effect on W2 stage membership ................................................... 55
Table 4.5 Intervention effects on stage transition ............................................................. 56
Table 4.6 Hypothesis of stage-specific psychosocial predictors ...................................... 65
Table 4.7 Intervention components and corresponding sessions ...................................... 66
Table 4.8 Predictive effect of psychosocial factors on stage transition ............................ 71
Table 4.9 Baseline characteristics by intervention status ................................................. 72
Table 4.10 Intervention effects on psychosocial factors ................................................... 74
Table 4.11 Predictive effects of psychosocial factors at W2 on stage transition between
W2 and W3 (odds ratio) .................................................................................................... 75
Table A.1 Intervention effects on stage transition (multilevel model) ............................. 98
Table A.2 Intervention effects on psychosocial factors (multilevel model) ................... 100

xi

LIST OF FIGURES
Figure 2.1 Conceptual framework .................................................................................... 24
Figure 3.1 CONSORT flowchart of participants between baseline and W3 .................... 34
Figure 3.2 Simple illustration of the Markov chain model ............................................... 35
Figure 3.3 Multigroup Markov model testing the moderating effect of the intervention on
the transition probability ................................................................................................... 35
Figure 3.4 Alternative parameterization of the intervention effect ................................... 36
Figure 3.5 Latent proportional change model ................................................................... 37
Figure 3.6 Structural modeling for the proportional latent change score (LCS) model ... 39
Figure 4.1 CONSORT flow diagram of 791 participants ................................................. 51
Figure 4.2 Estimated transition probabilities by intervention groups ............................... 55
Figure 4.3 Structural modeling setup for the proportional latent change score (LCS)
model................................................................................................................................. 70
Figure 4.4 Possible stage transition patterns ..................................................................... 71
Figure 4.5 HIV disclosure stage transition matrix ............................................................ 74
Figure A.1 Multilevel Markov chain model ..................................................................... 97
Figure A.2 Structural modeling setup for the multilevel proportional latent change score
(LCS) model...................................................................................................................... 99

xii

CHAPTER 1
INTRODUCTION
1.1 HIV EPIDEMIC
1.1.1 Global HIV epidemic
According to the Joint United Nations Programme on HIV and AIDS (UNAIDS),
by the end of 2018, there were 37.9 million people living with HIV (PLHIV) worldwide
(Joint United Nations Programme on HIV/AIDS, 2019). Among 36.2 million adults (aged
between 15 and 49 years old) living with HIV, 18.8 million (52%) were women. Data
from the World Health Organization (WHO) showed that the prevalence of HIV among
adults aged between 15 and 49 years old was 0.8% worldwide, which ranged between
0.1% (in Eastern Mediterranean and Western Pacific) and 3.9 (in Africa) (World Health
Organization, 2019).
In 2014, UNAIDS launched its ambitious 90-90-90 target for 2020. Simply, 90%
of PLH would know their HIV status, 90% of people diagnosed with HIV infection
would receive treatment, and 90% of PLH on treatment would reach viral suppression.
Based on the 2019 UNAIDS data, by the end of 2018, 79% of PLH have known their
HIV status, 78% of PLH who know their status have received treatment, and 86% of PLH
on treatment have reached viral suppression (Joint United Nations Programme on
HIV/AIDS, 2019). Six countries (Botswana, Cambodia, Denmark, Eswatini, Namibia and
the Netherlands) have already reached the 90–90–90 targets. Another 9 countries
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(Australia, France, Germany, Iceland, Ireland, Rwanda, Spain, Thailand, and United
Kingdom) have reached the threshold of 73% regarding viral load suppression among all
PLH yet gaps were identified particularly in the first two targets. Key populations,
including men who have sex with men, people who inject drugs, sex workers, and
transgender people, together with their sexual partners, accounted for 54% of new HIV
infections worldwide. AIDS-related mortality has declined by 33% since 2010.
Tuberculosis (TB) remains the leading cause of AIDS-related deaths. Data on
government spending for HIV between 2016 and 2018 showed that among 70 low- and
middle-income countries, 45 reported an increase in spending since 2010. An increase of
more than 50% were reported by 36 countries.
1.1.2 HIV epidemic in China
As reported on the 5th National Conference on HIV/AIDS in China, there were
820,756 reported people living with HIV (PLHIV) in China by the end of June 2018,
among which 80.4% were receiving ART (China Center for Disease Control and
Prevention, 2018). The 2019 UNAIDS data showed that in China, 83% of PLH who
know their status have received the treatment, and 94% have suppressed viral loads (Joint
United Nations Programme on HIV/AIDS, 2019). Although a low prevalence rate of
0.037% was found for the overall population, high prevalence was detected in some areas
(Yunnan, Sichuan, Guangxi) and among certain groups. The percentage of sexually
transmitted cases among the newly diagnosed ones had increased from 33.1% in 2006 to
92.2% in 2014, with heterosexual transmission increasing from 30.6% to 66.4% and
becoming the dominant route of infection (National Health and Family Planning
Commission of People’s Republic of China, 2015). Based on the data released by China

2

CDC, among newly diagnosed HIV cases in 2017, 69.6% were contracted via
heterosexual sex, 25.5% were MSM, and 3.2% were drug injections (China Center for
Disease Control and Prevention, 2018). China increased government spending on HIV
from about US$ 400 million in 2010 to more than US$ 1 billion in 2018 (Joint United
Nations Programme on HIV/AIDS, 2019). Based on the 2018 Global AIDS Monitoring
Country Progress Report, from 2008 to 2017, the number of HIV testing medical and
health facilities increased from 7,642 to 30,435 (Joint United Nations Programme on
HIV/AIDS, 2018b).

1.2 DEFINITION OF HIV DISCLOSURE
As early as 1999, the WHO described HIV as “a process to inform others about
one’s HIV positive status by the person himself or by a third party with or without
consent” (World Health Organization, 1999). In the 2011 review of facilitating HIV
disclosure across diverse settings, Obermeyer argued that “rather than being a one-time
event, disclosure is often a gradual process of disclosing to an increasing number of
others in one's networks over time” (Obermeyer, Baijal, & Pegurri, 2011). This definition
has been used in the evaluation of partner HIV disclosure interventions. For example,
partner disclosure rate was calculated by the proportion of partners to whom participants
had disclosed among partners they had in the past 6 months (Conserve, Groves, &
Maman, 2015).
Regarding a specific disclosure target, in 2004, the World Health Organization
(WHO) published a review paper on HIV disclosure (World Health Organization, 2004).
The paper argues that disclosure should be conceptualized as a process rather than a onetime event of disclosure/nondisclosure. For example, a disclosure process can be
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composed of decision-making, action, and post-disclosure adaptation. Such
conceptualization has been incorporated in the Disclosure Process Model (DPM) which
describes “how people make decisions to disclose and how people are affected by their
disclosure decisions” (Chaudoir & Fisher, 2010).
Specifically, existing literature has proposed and investigated the decision-making
process of disclosure. For example, a 6-step process was developed by Kimberly
(Kimberly, Serovich, & Greene, 1995). The first step is adjustment to the diagnosis.
Appropriate adjustment to the diagnosis can help individuals develop personal acceptance.
The second step is the assessment of personal disclosure skills. Individuals need to
evaluate whether they have adequate level of skills necessary for disclosure. The third
step is the assessment of the potential disclosure recipient. Individuals may go through
members in their social network and choose an individual as the disclosure recipient. The
fourth step is the assessment of the circumstances for disclosure. Some circumstances
may not be appropriate for disclosure to certain individuals. The fifth step is the
anticipation of recipients’ potential reactions. The final step is the identification of
disclosure motivation.

1.3 OUTCOMES OF HIV DISCLOSURE
According to the DPM, disclosure can affect both individual, dyadic, and social
contextual outcomes (Chaudoir & Fisher, 2010). Individual outcomes include
psychological, behavioral, and physical well-being, dyadic outcomes include liking,
intimacy, and trust, social contextual outcomes include cultural stigma and norms for
disclosure. For the person who discloses, HIV disclosure was associated with initiation of
ART and better ART adherence, better clinical outcomes and psychological wellbeing, as
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well as higher levels of social support and closer relationships with the disclosure
recipient (Bulali, Kibusi, & Mpondo, 2018; Dessie et al., 2019; Hodgson et al., 2014;
Mayfield Arnold, Rice, Flannery, & Rotheram-Borus, 2008; Stutterheim et al., 2011;
Weiss, 2004). Specifically, for partner disclosure, awareness of partner’s HIV status
allows the disclosure recipient to get HIV testing and negotiate safer-sex practices, which
is critical for the risk reduction of HIV transmission (Conserve et al., 2015). However,
HIV disclosure may not always be associated with positive outcomes. HIV disclosure can
lead to HIV-related stigma, blame, abandonment, physical and emotional abuse, worse
partner relationship, and loss of social support (Chaudoir, Fisher, & Simoni, 2011; Hawk,
2007; Mayfield Arnold et al., 2008; Stutterheim et al., 2011; Weiss, 2004).

1.4 PSYCHOSOCIAL FACTORS INFLUENCING DISCLOSURE DECISION-MAKING
Several key psychosocial factors have been identified to influence the decisionmaking of disclosure. According to the consequence theory of HIV disclosure, people
assess the rewards and costs for disclosure and a decision to disclosure is made once the
rewards outweigh the costs (Serovich, 2001). Based on the Disclosure Decision-Making
Model (DDMM), besides assessment of the costs and rewards for HIV disclosure,
patients also evaluate their ability to disclosure (i.e., disclosure self-efficacy) (Greene et
al., 2012). The individual’s likelihood to disclosure increases as disclosure self-efficacy
increases.
Moreover, different effects have been found regarding how these factors influence
HIV disclosure behavior. For example, one study conducted among HIV positive MSM
found that disclosure costs and self-efficacy predict HIV disclosure, while disclosure
rewards do not (Serovich, Laschober, Brown, & Kimberly, 2018). However, another
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study conducted among HIV positive women found disclosure rewards to be a predictor
for HIV disclosure, while disclosure costs were not (Serovich, Lim, & Mason, 2008).

1.5 CHILDREN IN TERMS OF HIV DISCLOSURE
Regarding children in HIV disclosure, most studies have focused on disclosure of
a child’s HIV status (i.e., pediatric HIV disclosure). A systematic review on pediatric
HIV disclosure differentiated disclosure as full disclosure, partial disclosure, no
disclosure, and deflected disclosure (Britto, Mehta, Thomas, & Shet, 2016). Full
disclosure involves the mentioning of HIV specifically. Partial disclosure involves
mentioning the illness in a way that was consistent with HIV but without the term “HIV”.
No disclosure means telling nothing about the illness. Deflected disclosure involves
deceptive description of the illness by telling the children about less-stigmatized
conditions (e.g., asthma, cancer) unrelated to HIV.
In Tasker’s book, How Can I tell you, a four-phase disclosure model was
described (Tasker, 1992). The first is the secrecy/privacy phase which occurs
immediately after learning the child’s diagnosis. The second is the exploratory phase
characterized by parents’ willingness to disclose to a close friend or family member.
Meanwhile, the parent will often provide some information (not directly mentioning
HIV) regarding the child’s illness and needs for medical visits. The third phase is the
readiness phase characterized by parents’ willingness and planning of fully disclosing to
the child. The fourth is the disclosure phase when parents fully disclosure to the child
with mentioning the word “HIV”.
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1.6 PARENTAL HIV DISCLOSURE
1.6.1 Disclosure rate
With prolonged lives thanks to ART, parents living with HIV (PLH) are more likely to
raise their children to adolescence or even adulthood. Meanwhile, PLH face ongoing
challenges regarding whether, when, and how to disclose their HIV-positive status to
children (i.e., parental HIV disclosure). A systematic review found that parental HIV
disclosure rate ranged from 20%-97% in high-income countries. Lower rates ranging
from 11% to 44% were found in resource-constrained countries. According to the China
Stigma Index Report, less than half of PLH reported that their children were aware of
their HIV status (Institute of Social Development Research, 2009). An even lower rate of
25% was found in the 2012 survey among 1254 PLH who had children between 5-16
years old (Qiao et al., 2015).
1.6.2 Disclosure outcomes
Both positive and negative outcomes have been reported regarding parental HIV
disclosure, both for the children, for the parent, and for the family(Conserve et al., 2015).
For the children, although some studies reported short-term negative consequences on
externalizing problems, internalizing behaviors, anxiety and depression, and school
performance, others suggested that most children, particularly younger children, adjusted
to parental HIV disclosure over time in terms of the aforementioned psychosocial
functioning factors. For the parents, parental HIV disclosure was associated with better
ART adherence and lower levels of depression and anxiety. Moreover, parents also
reported higher levels of social support from the children, as well as a closer parent-child
relationship, and better family communication.
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1.6.3 Barriers to parental HIV disclosure
Relatively low disclosure rate can be caused by several barriers including
concerns that children are too young to understand, poor parent-child relationship and
family functioning, limited parent-child communication skills, and lack of accurate HIV
knowledge (Clifford, Craig, McCourt, & Barrow, 2013).
Regarding the concerns about children’s young age, studies on pediatric HIV
disclosure argued that the disclosure should be conceptualized as a process “that
considers the child’s social, emotional, and developmental level”(Cantrell, Patel,
Mandrell, & Grissom, 2013). Based on Piaget’s cognitive development theory, three
critical developmental stages are identified --- the preoperational stage, the concrete
operational stage, and the formal operational stage. A structured sequence of HIV
infection information was recommended for children at three different developmental
stages with suggested ages being 6-7 years, 8-11 years, and 11-14 years, respectively.
Regarding parent-child relation and family functioning, both quantitative and
qualitative studies have found that poor parent-child relationship was a key barrier to
parental HIV disclosure (Clifford et al., 2013; Kennedy et al., 2010; Osingada, Okuga,
Nabirye, Sewankambo, & Nakanjako, 2017). Moreover, studies on parental HIV
disclosure preparation activities have found that besides thinking about and making
disclosure plans, PLH also tried to improve family relationships in order to better prepare
their children for the upcoming disclosure (Gachanja, Burkholder, & Ferraro, 2014a).
Regarding poor intergenerational communication skills, studies have suggested
that intergenerational communication was the most modifiable causal pathway for
family-based interventions (van Rooyen et al., 2016). Contrary to traditional strategies
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focusing on the individual patient or considering the family only as a source of social
support, family-based interventions emphasize the educational, relational, and personal
needs of all family members (Fisher & Weihs, 2000).

1.7 STAGE MODELS TO FILL THE INTENTION-BEHAVIOR GAP
The relatively low parental HIV disclosure rate can also be due to the failure of
translating disclosure intention to disclosure behavior (i.e., the intention-behavior gap).
Studies examining HIV disclosure to partners showed significantly lower actual
disclosure rates compared to intended disclosure rates in both developed and developing
countries (Maman & Medley, 2007).
To fill the intention-behavior gap, researchers argued that stage models of
behavior change should be applied (Schwarzer, 2016; Velicer & Prochaska, 2008).
Specifically, the stage models posit that people pass through an ordered set of
qualitatively different stages to make behavior change (Weinstein, Rothman, & Sutton,
1998). Based on the Transtheoretical Model (TTM), individuals move through five stages
of change: 1) the pre-contemplation, in which people do not intend to take action within
the next 6 months; 2) the contemplation, in which people intend to change within the next
6 months; 3) the preparation, in which people intend to take action usually within the next
month; 4) the action, in which people have made specific overt behavior change within
the past six months; 5) the maintenance, in which people have made specific overt
behavior change for more than 6 months.
Although the TTM has been widely used in physical activity, smoking cessation,
and substance use cessation interventions, it is not readily applicable for the HIV
disclosure process as the definition of most stages is based on the duration of a certain
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behavior or behavioral intention. Specifically, for the pre-action stages, differentiation
between the preparation stage and the contemplation stage is based on whether there’s an
intention to make immediate (i.e., within the next month) behavior change or not. It fails
to capture the preparation and planning component which plays a key role in translating
disclosure intention into actual behavior. For the post-action stages, differentiation based
on the duration of a certain behavior fails to capture the feature of HIV disclosure action
which may progress in terms of depth and width, but not duration.
As argued in the HAPA (Schwarzer, 2016), the intention-behavior gap can be
bridged by adopting the stage models where the role of action planning (i.e., making
“When-Where-How” plans) is pinpointed. HAPA posits that engaging in behavior
change starts with forming an intention, followed by a stage of planning, and ends in
action. Briefly, there are three critical stages: 1) the pre-intention stage, in which people
have not yet decided to act; 2) the intention stage, in which people have decided to act
and started making plans but have not yet started action; 3) the action stage, in which
individuals make actual behavior change.

1.8 RESEARCH GAPS IN PROGRAM EVALUATION
Although HIV disclosure has been depicted as a process with several key steps,
such conceptualization has not been incorporated in the evaluation of parental HIV
disclosure interventions. In a systematic review of existing parental HIV disclosure
interventions, intervention effects have been evaluated focusing on the actual HIV
disclosure action rather than the process (Conserve et al., 2017). Moreover, although
HAPA has been applied to behavior change interventions on physical exercise, smoking
cessation, oral health, and nutrition, the 3-stage operationalization has not been adopted
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in depicting HIV disclosure process. Therefore, the stage-specific predicting roles of key
psychosocial factors such as outcome expectancy and self-efficacy have not been well
studied in the context of HIV disclosure.

1.9 AIMS OF THE DISSERTATION STUDY
To address the research gaps in HIV disclosure intervention evaluation, this
dissertation project aims to apply the HAPA model to the program evaluation of an
existing parental HIV disclosure intervention. This dissertation project builds on the
“Interactive Communication with Openness, Passion, and Empowerment” (ICOPE)
intervention funded by an NIH R01 (Principal investigator: Dr. Xiaoming Li). Aimed at
assisting PLH to make a well-planned and developmentally appropriate HIV disclosure to
their uninfected children, a theory-driven intervention was conducted among 791 PLH
with children aged between 6-15 years in Guangxi, China. Participants receive interactive
training sessions focusing either on cognitive and behavioral skills regarding parental
HIV disclosure (i.e., the intervention group) or on nutrition education (i.e., the control
group). Participants completed the baseline survey before intervention and 6 waves of
follow-ups were conducted every 6 months.
This dissertation research project will contribute to the theoretical aspect of HIV
disclosure research by 1) applying the HAPA to the operationalization of HIV disclosure
stage; 2) evaluate the intervention effects of a theory-based parental HIV disclosure
intervention on HIV disclosure stage; 3) evaluate the intervention effects of a theorybased parental HIV disclosure intervention on disclosure-related psychosocial factors; 4)
assess the predictive effects of disclosure-related psychosocial factors on HIV disclosure
stage transition. Three major research questions were addressed by this study:

11

1) is there any intervention effect on HIV disclosure stage transitions?
2) is there any intervention effect on disclosure-related psychosocial factors?
3) do disclosure-related psychosocial factors yield stage-specific predictive effects
on disclosure stage transition?

12

CHAPTER 2
BACKGROUND AND SIGNIFICANCE
2.1 PROBLEM STATEMENT
According to the Joint United Nations Programme on HIV and AIDS (UNAIDS),
by the end of 2018, there were 37.9 million people living with HIV (PLHIV) worldwide
(Joint United Nations Progamme on HIV/AIDS, 2019). As reported on the 5th National
Conference on HIV/AIDS in China, by the end of June 2018, there were 820,756
reported PLHIV in China, among which 80.4% were receiving ART (China Center for
Disease Control and Prevention, 2018). The 2019 UNAIDS data reported that 83% of
PLH in China who know their status have received the treatment, and 94% have reached
viral suppression(Joint United Nations Programme on HIV/AIDS, 2019).
China national statistics showed that HIV infections were largely concentrated in
the childbearing 20–29 and 30–39 age groups, which together account for 70.0% of all
infections (Huang et al., 2015). A cross-sectional survey conducted in 2012 among 2987
PLHIV in Guangxi, China showed that most (n=2458; 82.3%) participants had at least
one child. With prolonged lives thanks to ART, parents living with HIV (PLH) are more
likely to raise their children to adolescence or even adulthood. Over the course of their
lifetime, PLH face challenges regarding telling their HIV-positive status to children (i.e.,
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parental HIV disclosure). According to the China Stigma Index Report, less than half of
PLH reported that their children were aware of their HIV status (Institute of Social
Development Research, 2009). Parental HIV disclosure is even more challenging when it
comes to younger children. A disclosure rate of 25% was found in the 2012 survey
among 1254 PLH who had children between 5-16 years old (Qiao et al., 2015).
In 2011, the World Health Organization (WHO) published the Guideline on HIV
Disclosure Counselling for Children Up to 12 Years of Age (World Health Organization,
2011). Although the guideline has been focused on pediatric HIV disclosure (i.e.,
disclosing children’s HIV status), it also provided some recommendations that children of
school age should be told of their parent’s HIV status. Specifically, considering the
developmental stage of younger children, HIV disclosure should be conducted
incrementally to accommodate their cognitive skills and emotional maturity. Till now,
there’s no standardized guideline regarding parental HIV disclosure counseling services
launched in China.

2.2 THEORETICAL MODELS OF PARENTAL HIV DISCLOSURE INTERVENTIONS
2.2.1 Social Cognitive Theory (SCT)
Bandura (Bandura, 1994) posited the Social Cognitive Theory of HIV-related
behaviors. The author highlighted that although knowledge of health risks and constituent
skills are important preconditions for self-directed change, people need to be provided
with the behavioral means, resources, and social supports for behavioral changes. The
two central tenets of the theory are outcome expectancies and self-efficacy. In terms of
outcome expectancies, a person needs to believe that the benefits of a certain behavior
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outweigh the costs. In terms of self-efficacy, a person needs to believe that he or she can
implement a certain behavior with acquired skills under counteracting circumstances.
Specifically, for parental HIV disclosure, outcome expectancies can be either
positive (i.e., the anticipation of social approval or recognition by the child) or negative
(i.e., the anticipation of rejection from the child). Self-efficacy regarding parental HIV
disclosure is defined as the perceived ability to conduct the disclosure event in a
successful manner.
2.2.2 The Disclosure Decision-Making Model (DDMM)
Built on several theoretical perspectives including the social cognitive theory,
Greene et al. (Greene et al., 2012) posited the Disclosure Decision-Making Model
(DDMM) with an emphasis on key predictors of disclosure likelihood and disclosure
depth. Separate models were developed for the likelihood of disclosure and for disclosure
depth among people who have already disclosed. Briefly, the DDMM argues that people
make disclosure decisions based on the evaluation of three major factors: the diagnosis
(the information), the potential receiver of disclosure, and the disclosure self-efficacy.
The five major components in the information are stigma, disease prognosis, disease
symptoms, discloser’s preparation, and the relevance of the diagnosis to others. In terms
of assessing the potential receiver, the discloser evaluates the relationship quality, the
anticipated reaction (including both short-term reaction and long-term consequence), and
the confidence in response (i.e., the certainty that the receiver will respond in the way that
the discloser anticipates).
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2.2.3 The Disclosure Process Model (DPM)
With the two aforementioned models focusing on the decision-making process of
disclosure, the Disclosure Process Model (DPM) posited by Chaudoir et al. (Chaudoir et
al., 2011) incorporated disclosure outcomes as a key component of HIV disclosure.
Similar to the DDMM, the decision-making of HIV disclosure depends on the antecedent
goals, and the disclosure event is characterized by the depth, duration, and breadth of the
disclosure. Moreover, the reaction of the confidant was added to comprehensively
measure disclosure event. In terms of disclosure outcomes, both the individual-, dyadicand social contextual- level factors were taken into consideration. One key feature of the
DPM is the mediating process linking the disclosure event to disclosure outcomes. In
addition, the DPM recognizes the reciprocity of disclosure by adding the feedback loop
linking disclosure outcomes back to the decision-making process of future disclosure.

2.3 PSYCHOSOCIAL FACTORS INFLUENCING HIV DISCLOSURE
Several psychosocial factors have been identified to influence HIV disclosure in
the three models mentioned above. The first is outcome expectancy. According to the
consequence theory of HIV disclosure, people assess the rewards and costs for disclosure
and a decision to disclosure is made once the rewards outweigh the costs (Serovich,
2001). Defined as “anticipated reaction”, the DDMM further differentiated anticipated
response (i.e., immediately after the disclosure) and anticipated outcome (i.e., the
endpoint results of the disclosure). In DPM, outcome expectancy was defined as
antecedent goals with the approach goals as pursing rewards and avoidance goals as
preventing the costs.
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The second factor is self-efficacy, which refers to patients’ confidence in their
ability to disclosure (Greene et al., 2012). Aligning with Bandura’s argument that selfefficacy should be measured for a specific task, the DDMM specified that disclosure selfefficacy refers to sharing the diagnosis, not general communication. The individual’s
likelihood of disclosure increases as disclosure self-efficacy increases. Moreover, for
those who have disclosed, higher levels of disclosure self-efficacy relate to higher levels
of disclosure depth.
Besides outcome expectancy and self-efficacy, the DDMM identifies an
additional construct called “confidence in response”. It refers to the discloser’s level of
certainty regarding how the disclosure target would respond. Although not directly
related to the likelihood of disclosure, confidence in response was hypothesized to
influence the likelihood via disclosure self-efficacy. A similar construct “likelihood of the
anticipated outcome” was posited in the HIV disclosure anxiety model (Evangeli &
Wroe, 2017).

2.4 PARENTAL HIV DISCLOSURE INTERVENTION PROGRAMS
Considering the potential benefits of disclosing HIV status to children, several
interventions have been conducted to assist PLH with parental HIV disclosure. This
section will review the evaluation of previous parental HIV disclosure interventions.
2.4.1 Interventions based on the Social Cognitive Theory (SCT)
Rotheram-Borus et al. (Rotheram-Borus, Lee, Gwadz, & Draimin, 2001)
implemented a randomized controlled trial among 307 PLH with adolescent children in
the US. The intervention group received two modules with the first model involving
parents only and the second module involving both parents and their children. Module 1
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covered topics on coping with HIV and disclosure decision-making. Topics in Module 2
covered both parent topics (e.g., making custody plans, parent-child communication) and
youth topics (e.g., coping with parent’s illness and resolving family conflicts). The
control group received standard HIV care. Follow-ups were conducted every 3 months
over 2 years. Disclosure outcome variable was whether the parent disclosed to his/her
child or not. The results showed no statistically significant difference in disclosure
between the intervention group and the control group.
2.4.2 Interventions based on the Disclosure Decision Making Model (DDMM)
The Amagugu intervention with a pre- and post- design was developed and pilot
tested among 24 HIV-positive mothers with children aged 6-9 years in rural South Africa
(Rochat, Mkwanazi, & Bland, 2013). The intervention was further scaled up to 281 HIVpositive mothers with children aged 6-10 years in rural South Africa (Rochat, Arteche,
Stein, Mkwanazi, & Bland, 2014). Six structured counseling sessions covering two
intervention stages were delivered. The pre-disclosure stage involved preparing and
training the mother to disclosure, and the post-disclosure stage involved counseling on
health promotion and custody planning. Impact evaluation was conducted immediately
after the 6- to 8-week intervention. Disclosure outcome variable was whether participants
partially, fully, or not disclosed to their child. In the first study, 11/24 fully disclosed to
their children and 13/24 partially disclosed. In the second study, 60% of participants fully
disclosed and 40% partially disclosed.
The “Teaching, Raising, And Communicating with Kids” (TRACK) program was
developed by Murphy et al. (Murphy, Armistead, Marelich, Payne, & Herbeck, 2011) and
implemented among 80 HIV-positive mothers with children aged 6-12 years in the US.
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The intervention targets familial communication and parenting skills in the context of
parental HIV disclosure. In the intervention group, participants received 3 sessions with
topics on children’s development, benefits and risks of parental HIV disclosure, and
parent-child communication. Behavioral exercises for disclosure were also practiced. In
the control group, participants received standard care. Follow-ups were conducted every
3 months over the next 9 months. Disclosure outcomes included whether participants
disclosed to their children or not and disclosure self-efficacy. The results showed that
participants in the intervention group were 6 times more likely to disclose their HIV
status to their children (OR = 6.33, 95% 1.64, 24.45). A statistically significant increase
in disclosure self-efficacy was also found.
2.4.3 Interventions based on the Decision Process Model (DPM)
Simoni et al. (Simoni et al., 2015) implemented a randomized controlled trial built
on the Chinese Parental HIV Disclosure Model (which was adapted from the DPM)
among 20 PLH in China. The intervention group received three counseling sessions
regarding disclosure decision-making, HIV disclosure event, and disclosure
consequences. In session one, participants shared stories of their HIV diagnosis and their
current disclosure status (to partners or family members) with the nurse interventionist. In
session 2, the nurse provided psycho-education regarding what to be expected from their
children during the disclosure process. In session 3, participants developed a plan for
achieving a certain goal along the disclosure continuum. The control group received
standard care. Follow-ups were conducted immediately after the 4-week intervention, and
at 13 weeks. Disclosure continuum was measured with a 7-point scale ranging from no
disclosure (0) to complete disclosure and communication about HIV (6). Disclosure
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distress and self-efficacy were also measured. The results showed statistically significant
decrease in disclosure distress (OR = 0.17, 95% CI 0.03, 0.91), increase in self-efficacy
(OR = 9.00, 95% CI 2.06, 39.29), as well as shift towards the higher end of the disclosure
continuum (β=1.40, 95% CI 0.31, 2.50).

2.5 METHODOLOGICAL GAPS IN IMPACT EVALUATION OF PARENTAL HIV
DISCLOSURE INTERVENTIONS

2.5.1 HIV disclosure as a process
HIV disclosure has been described as a process of decision-making to determine
whether, when, and how to disclose (Omarzu, 2000). The first stage is about disclosure
intention formation and the latter two stages are about preparation and planning for
intention translation. The HIV/AIDS Resources & Community Health (ARCH) published
an HIV Disclosure Guide (HIV/AIDS Resources & Comunity Health, 2016). HIV
disclosure is depicted as a process starting from recovery from the diagnosis and selfeducating, moving into preparation and planning for disclosure, and finally translating
into disclosure action. In the preparation and planning phases, patients create disclosure
plans by setting disclosure goals, deciding where, when, and how to disclose, as well as
seeking disclosure support.
However, among most parental HIV disclosure interventions, intervention effects
have been evaluated focusing on the actual HIV disclosure action rather than the process.
Two studies measured HIV disclosure action as a binary yes-or-no measure, one
measured disclosure as no disclosure, partial disclosure using the word virus, and full
disclosure using the word HIV, and one measured disclosure as a 0-6 scale ranging in
disclosure breadth (i.e., the topics covered in the communication). To the best of our
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knowledge, no measure has been developed to measure HIV disclosure process starting
from intention-formation and ending in disclosure action.
2.5.2 Other HIV disclosure-related outcomes
As suggested by Simoni et al. (2015), HIV disclosure interventions should “aim
more to diminish distress than achieve a specific behavioral outcome” (Simoni et al.,
2015). Therefore, disclosure beliefs, HIV disclosure distress, and disclosure self-efficacy
need to be considered in impact evaluations of HIV disclosure interventions (Simoni et
al., 2015).
Moreover, HIV disclosure is a process that takes time. A study among PLH in
Kenya showed that the preparation for disclosure often took several years before the
actual disclosure event (Gachanja et al., 2014a). In addition, the intention-behavior gap
identified in multiple health behaviors also exists in terms of HIV disclosure. Studies
examining HIV disclosure to partners showed significantly lower actual disclosure rates
compared to intended disclosure rates in both developed and developing countries
(Maman & Medley, 2007). Therefore, single long-term measures such as the HIV
disclosure event may fail to capture the short- to medium-term efficacy of interventions
in terms of changes in disclosure-related psychosocial factors.

2.6 HEALTH ACTION PROCESS APPROACH
The stage models of behavior change have been widely used to depict the process
of making behavior change (Schwarzer, 2016; Velicer & Prochaska, 2008). Specifically,
the stage models posit that people pass through an ordered set of qualitatively different
stages to make behavior change (Weinstein et al., 1998). Among existing stage models,
the Health Action Process Approach (HAPA) aligns well with the HIV disclosure process.
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According to HAPA, engagement in behavior change starts with forming an intention,
followed by a stage of planning, and ends in action. Briefly, there are three critical stages:
1) the pre-intention stage, in which people have not yet decided to act; 2) the intention
stage, in which people have decided to act and started making plans but have not yet
started action; 3) the action stage, in which individuals make actual behavior change.
However, to the best of our knowledge, the HAPA has never been applied in HIV
disclosure research.
The importance of psychosocial factors such as outcome expectancy and selfefficacy is emphasized in HAPA. Outcome expectancy is defined as beliefs about the
positive and negative outcomes of the anticipated behavior, and self-efficacy is defined as
one’s confidence in being capable of performing the behavior (Schwarzer, 2016).
Different stages are characterized by psychological similarities within stages and
psychological differences between stages (Schüz, Sniehotta, Mallach, Wiedemann, &
Schwarzer, 2008). Theoretically, pre-intenders will show lower perceived rewards and
self-efficacy but higher perceived costs than intenders. Intenders will show lower selfefficacy than actors, but no differences in perceived costs or rewards are expected.
Therefore, for pre-intenders, higher levels of perceived rewards and self-efficacy, as well
as lower levels of perceived costs, would promote stage progression. For intenders,
higher levels of self-efficacy would promote stage progression, while lower levels of
costs and higher levels of rewards would prevent stage regression.
As emphasized by HAPA, as people pass different stages to make behavior
change, self-efficacy should be differentiated by the stages of change (i.e., intentionformation, behavior initiation, and behavior maintenance) (Schwarzer et al., 2003).
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Action self-efficacy plays a key role in the early intention formation stage. People with
high action self-efficacy tend to imagine potential outcomes of diverse strategies and are
more likely to initiate a new behavior. People with low action self-efficacy are more
likely to imagine failure and tend to procrastinate (Schwarzer, 2011).
In addition, the HAPA posits that planning precedes the initiation of behavior
change action. By planning, the intention is more likely to be translated into action.
Further differentiation is made between action planning (i.e., when-where-how plans) and
coping planning (i.e., anticipating barriers and developing corresponding self-regulatory
strategies). Specifically, for HIV disclosure, patients create disclosure plans by setting
disclosure goals, deciding where, when, and how to disclose, as well as seeking
disclosure support (HIV/AIDS Resources & Comunity Health, 2016).
Although psychosocial factors such as disclosure self-efficacy have been
considered in program evaluation of previous parental HIV disclosure interventions, as
HIV disclosure has not been operationalized as a 3-stage process, limited understanding
has been developed regarding whether such psychosocial factors yield stage-specific
roles on HIV disclosure stage transition as hypothesized in HAPA.

2.7 CONCEPTUAL FRAMEWORK
The proposed dissertation was guided by the conceptual framework diagrammed
in Figure 2.1. There were two main studies in this dissertation. The first study 1)
modelled the HIV disclosure stage (pre-intention, intention, and action) and the transition
matrix based on the 3-stage HAPA, and 2) evaluated intervention effects on HIV
disclosure stage transition. The second study evaluated 1) intervention effects on parental
HIV disclosure-related psychosocial factors (disclosure knowledge, disclosure outcome
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expectancy including the perceived costs and rewards, disclosure action self-efficacy, and
disclosure action planning), and 2) the stage-specific predictive effects of these factors on
HIV disclosure stage transition.

2.8 PURPOSE
The HAPA has been widely used in behavior change interventions on smoking
cessation, physical exercise, nutrition, and dental health. However, less is known about
whether this model is applicable to HIV disclosure intervention. Given the lack of
research applying the stage models to the operationalization of HIV disclosure process,
one of the main purposes of the proposed study is to model HIV disclosure stages based
on the HAPA.
Psychosocial Factors
• Knowledge
• Perceived costs
• Perceived rewards
• Action self-efficacy
• Action planning

Intervention

Pre-intention

Intention

HIV disclosure stage transition matrix

Figure 2.1 Conceptual framework
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Action

Moreover, although several key psychosocial factors have been identified in
leading HIV disclosure models, previous studies have focused on the linear relationship
between psychosocial predictors and the likelihood of disclosure action. Little is known
about whether such factors yield stage-specific predictive effects of HIV disclosure stage
transitions. Therefore, the other purposes of this study are to evaluate intervention effects
on the proposed psychosocial factors, as well as to examine how these factors influence
HIV disclosure stage transitions.
The proposed research will build on past research on HIV disclosure by
conceptualizing and operationalizing it as a process. Instead of focusing on actual HIV
disclosure behavior, such operationalization gives credits to participants who make
progress in the early stages before HIV disclosure action is conducted. Moreover, it will
expand the application of HAPA to the HIV disclosure field by adopting the 3-stage
definition as well as examining the role action self-efficacy plays in disclosure stage
transition. Lastly, by assessing the potential stage-specific predictive effects of
psychosocial factors, this study will provide evidence for the development of future
stage-specific psychosocial interventions tailored to participants at different disclosure
stages.

2.9 RESEARCH QUESTIONS
Three major research questions were addressed in this study.
I. Is there any intervention effect on HIV disclosure stage transitions?
a. Does the intervention affect specific stage transition probabilities?
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b. Does the intervention influence the overall pattern of HIV disclosure stage
transition (i.e., backward transition or forward transition)?
II. Is there any intervention effect on disclosure-related psychosocial factors?
a. Does the intervention improve participants’ knowledge regarding parental HIV
disclosure?
b. Does the intervention improve participants’ perceived rewards regarding
parental HIV disclosure?
c. Does the intervention decrease participants’ perceived costs regarding parental
HIV disclosure?
d. Does the intervention improve participants’ perceived action self-efficacy
regarding parental HIV disclosure?
e. Does the intervention improve participants’ perceived action planning
regarding parental HIV disclosure?
III. Do disclosure-related psychosocial factors yield stage-specific predictive
effects on disclosure stage transition?
a. How does knowledge regarding parental HIV disclosure influence HIV
disclosure stage transition?
b. How does perceived rewards regarding parental HIV disclosure influence HIV
disclosure stage transition?
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c. How does perceived costs regarding parental HIV disclosure influence HIV
disclosure stage transition?
d. How does action self-efficacy regarding parental HIV disclosure influence HIV
disclosure stage transition?
e. How does action planning regarding parental HIV disclosure influence HIV
disclosure stage transition?
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CHAPTER 3
METHODOLOGY
3.1 STUDY SETTING
This intervention was conducted in Zhuang Autonomous Region of Guangxi (i.e.,
Guangxi). Guangxi is a province on China’s southwestern border with Vietnam, with a
total of 14 cities and 75 rural counties. It is a mountainous province with a large
population of minority ethnic groups. Guangxi was ranked third among all the provinces
of China in terms of HIV prevalence in the general population (1.30 per 1000) (Zheng et
al., 2018). By the end of 2016, more than 110,000 people in Guangxi were registered to
be living with HIV, among which 63,000 received treatment. Moreover, Guangxi was
ranked second in terms of late HIV diagnosis, with a percentage of 51% much higher
than the national average of 35.5% (Jin, Xiong, Wang, & Mao, 2016). Regarding the
route of transmission, Guangxi was ranked the highest for heterosexual transmission.
Among all registered HIV cases in 2016, more than 92% reported that they were infected
by heterosexual sexual transmission (Zheng et al., 2018).
To select participating sites, all 14 cities and 75 rural counties in Guangxi were
ranked in terms of number of reported HIV/AIDS cases. The top two cities (urban
centers) and the top eight rural counties with the largest number of reported HIV/AIDS
cases were selected to participate. Next, primary public HIV clinics in urban districts of
the two cities and in townships of the eight rural counties were identified, and a total of
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40 clinics were randomly selected from those clinics with at least 200 HIV/AIDS cases.
About 20 PLH were randomly selected from each of the 40 participating clinics
To minimize the confounding of contextual factors, stratified cluster
randomization was used to assign each clinic into either the intervention or the control
conditions. Briefly, all 40 clinics were first stratified into 10 strata (4 clinics/stratum)
based on their similarities in the number of PLHIV served and geographic locations (rural
vs. urban). Within each stratum, two clinics were randomly assigned to the intervention
group and the other two were assigned to the control group.

3.2 STUDY SAMPLE
Patients who have not disclosed their HIV infection to their seronegative children
aged between 6 to 15 years of age were recruited from 40 participating clinics. Inclusion
criteria were: at least 18 years of age; a confirmed diagnosis of HIV or AIDS; living with
at least one child 6 to 15 years of age; having not disclosed their HIV status to their
children; willing to consent one child to participate in the study. Exclusion criteria were:
linguistic, mental or physical inability to respond to assessment questions or to participate
in intervention; currently incarcerated or institutionalized for drug use or commercial sex;
plan to permanently relocate outside of the province within a year.
Medical staff or case managers at HIV clinics referred potential participants to
local team members who visited each clinic twice a week during the recruitment period.
If both father and mother in a family were eligible, the mother or the healthier parent was
invited to participate. The project protocol was approved by the Institutional Review
Boards (IRB) at Guangxi CDC in China and Wayne State University in the United States.
All participants provided written informed consent.
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3.3 INTERVENTION DELIVERY
In each clinic, two nurses or other paraprofessionals were trained and certified to
deliver the parent sessions (with separate training for intervention and control
facilitators). The two trained facilitators delivered the materials through discussions, roleplay, exercise, and/or games (for group sessions). The five two-hour parent intervention
and control sessions were delivered one session per week for five weeks in the clinics
where the parents are recruited.

3.4 DATA COLLECTION
Interviewers administered the baseline and all six-month follow-up surveys to the
parents in a private room (e.g., doctor’s office) at district/township clinics where these
parents were recruited. The interviewer read each question in the questionnaire, and the
participant gave an oral response to the interviewer. Clarifications were provided by the
interviewers as needed.

3.5 INTERVENTION CONTENTS
3.5.1 Intervention group
The parent curriculum consisted of five 2-hour interactive training sessions with
three specific components: child development, illness communication, and coping. The
first component focused on understanding the stages of childhood cognitive development
in the context of parental illness (Session #1 “Child’s readiness for disclosure”). The
second component focused on improving the parents’ cognitive and behavioral skills
related to parental HIV disclosure (Session #2 “Benefits and risks of disclosure”, Session
#3 “How to tell and what to tell”, and Session #4 “Disclosure is an ongoing process”).
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The third component focused on improving parental psychosocial well-being in adapting
to living with HIV/AIDS (Session #5 “Cope with my infection/illness”).
3.5.2 Control group
The attention control condition for parents was five 2-hour sessions of nutrition
education curriculum. The nutrition curriculum was modeled after the “Simply Good
Eating” curriculum (Sherman et al., 2012) and modified in accordance with current
“Dietary Guidelines for Chinese Residents” (Ge, Yang, & Chen, 2008). The modified
curriculum consisted of five 2-hour interactive training sessions with aims to increase
parents’ knowledge of nutrition (Session #1: Food variety; Session #2: Food for growing
child), healthy diets and cooking practice (Session 3: Fat, salt and sugar; Session 4:
Fruits, vegetables and minerals), and food safety (Session #5 “Food safety”).

3.6 KEY MEASURES
3.6.1 Disclosure-related outcomes
Primary outcome: HIV disclosure stage
One question was asked at both follow-ups to capture individual’s level of HIV
disclosure: 1 = “having not started disclosure in the past 6 months and no intention to
start”, 2 = “having not started disclosure in the past 6 months but is intending to start”, 3
= “having not started disclosure in the past 6 months but already made a plan”, 4 =
“started disclosing but not mentioning HIV”, 5 = “started disclosing with the word HIV”,
and 6 = “started disclosing with the word HIV and how I got infected”. This question was
not asked at baseline considering all participants had not disclosed at that time.
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Secondary outcome: HIV disclosure-related psychosocial factors
Participants were asked about their perceptions regarding the costs and rewards of
parental HIV disclosure. Disclosure costs were measured with 4 questions (e.g., “do you
agree that disclosing to children will impact their academic performance?”), and
disclosure rewards were measured with 5 questions (e.g. “do you agree that children will
provide more support after knowing your status?”). Responses ranged from 1 =
“completely disagree” to 4 = “completely agree”.
Considering the perceived costs and rewards depends on patients’ understanding
of parental HIV disclosure, participants were also assessed on their knowledge regarding
parental HIV disclosure using an author derived scale with 5 questions (e.g. “do you
agree that parental HIV disclosure should take children’s developmental stage into
consideration”). Responses ranged from 1 = “completely disagree” to 4 = “completely
agree”.
Participants’ action self-efficacy regarding parental HIV disclosure was measured
with an author derived scale with 9 questions. Sample questions are “how confident are
you that you can make a parental HIV disclosure plan?” and “how confident are you that
you can talk with children about basic HIV/AIDS knowledge?”. Responses ranged from
1 = “completely unconfident” to 5 = “completely confident”.
Participants’ action planning regarding parental HIV disclosure was measured
with an author derived scale with 9 questions. Three general questions regarding when,
who, and how to disclose and 6 specific questions (e.g., “how to explain what HIV is”,
“how to deal with children’s reaction”) were asked. Responses were 1 = “will never
consider”, 2 = “have not considered yet”, 3 = “considering”, and 4 = “already planned”.
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3.6.2 Baseline characteristics
Parent-level variables include parents’ demographics (age, gender, marital status,
level of education) and HIV-related variables (route of infection, and time since
diagnosis, antiretroviral therapy uptake, CD4 count, viral load). Child-level variables
include gender and age group (6-9 years, 10-12 years, and 13-16 years).

3.7 ANALYSIS PLAN
For the dissertation study, data from the baseline (W1) and the first two followups (W2 at 6 months and W3 at 12 months) were used. All analysis was conducted in
Stata 13.0 (College Station, TX) and Mplus 7.4 (Muthén & Muthén).
3.7.1 Randomization check
Chi-square tests and multivariate analysis of variance (MANOVA) were used to
investigate potential differences in baseline demographics and HIV-related variables. In
case there were differences between groups, the respective variable(s) were used as
covariates in the analysis of main outcome variables.
3.7.2 Attrition analysis
A CONSORT flowchart was provided (Figure 3.1). The rate of attrition and
whether it varies between intervention assignment were examined using chi-square tests.
MANOVA was conducted to test whether participants who completed the study differ in
any baseline variables compared to those who dropped out. In case there were
differences, the respective variable(s) were used as covariates in the analysis of the main
outcome variables.
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Enrollment
Randomized (n= 40 clusters
and 791 patients)

Allocation
Allocated to intervention (n= 20
clusters, 388 patients)

Allocated to intervention (n= 20
clusters, 403 patients)

Follow-up
Lost to follow-up at W2 (n= 17)
Lost to follow-up at W3 (n= 17)

Lost to follow-up at W2 (n= 36)
Lost to follow-up at W3 (n= 37)

Analysed (n= 377)
¨ Excluded from analysis (no
outcome measure at both W2 and
W3) (n= 26)

Analysis

Analysed (n= 374)
¨ Excluded from analysis (no
outcome measure at both W2 and
W3) (n= 14)

Figure 3.1 CONSORT flowchart of participants between baseline and W3
3.7.3 Main analysis
Intervention effects on HIV disclosure stage transition from W2 to W3
Methodologically, the central outcomes in stage theories such as HAPA are stage
transitions, which can be modeled using Markov chain approaches. A simple illustration
of the Markov chain is shown in Figure 3.2. C1 and C2 represent the latent stages at t and
t+1, u1 and u2 represent the observed variables at t and t+1. Three sets of parameters are
estimated: 1) latent status (i.e. stage) prevalence, which represents the prevalence of
latent status s at time t; 2) item-response probabilities which represent the probability of a
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given response to observed variable j, conditional on membership in a latent status s at
time t; and 3) transition probabilities which represent the conditional probability of a
transition to status s at time t + 1, given membership in status s at time t.
U1

U2
Itemresponse
probability

C1

C2

Itemresponse
probability

Transition
probability

Latent
prevalence

Figure 3.2 Simple illustration of the Markov chain model

Itemresponse
probability

A multigroup Markov model estimating group-specific transition matrix was
Item-

conducted. In this way, the intervention arm was treated as a grouping
variable, that is,
response
probability

we tested the moderating effect of the intervention on the transition probability (Figure
3.3).
U1

U2

Intervention

Figure 3.3 Multigroup Markov model testing the moderating effect of the intervention on
the transition probability
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To yield statistical estimates of the intervention effects on the transition matrix, a
different parameterization equivalent to the previous model was displayed in Figure 3.4.
Intervention effects can be modelled using a conditional multinomial logistic regression
shown in Table 3.1.

U1

U2

Intervention

Figure 3.4 Alternative parameterization of the intervention effect

Table 3.1 Illustration of the effect size of intervention on transitions

U2
1
2
3
1
b11+g11*Intervention b21+g21* Intervention 0
2
b12+g12*Intervention b22+g22* Intervention 0
3
0
0
0
Note: The b parameters are slopes for the multinomial regression of U2 on U1. The g
parameters are slopes for the intervention, varying over the U1 and U2 classes.
U1

Intervention effects on disclosure-related psychosocial factors
A latent change score (LCS) method was used to evaluate the intervention effect
on psychosocial factors. Both a structural model and a measurement model was included.
Based on the classical test theory, an observed score Y[t]n can be decomposed into a true
score y[t]n and a unique score u[t]n. This can be written as
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Y[t]n = y[t]n + u[t]n
For the difference between two time points, the true score at time t (y[t]n) is a
function of the true score at time t-1 (y[t−1]n) plus the change in the true score from time
t-1 to t (Δy[t]n). This can be written as
y[t]n = y[t-1]n + Δy[t]n
Therefore, the latent different score can be written as
Δy[t]n = y[t]n − y[t−1]n
To model the latent different scores, the proportional change model was used. The
predicted changes Δy[t]n are proportional to the state (or status) of the prior true score
y[t−1]n. Simply, it can be written as
Δy[t]n=β·y[t−1]n
where β is an estimated parameter that does not vary over time. The model was
depicted in Figure 3.5.
Δy[t]n
β
1
y[t]n

y[t−1]n
1

Figure 3.5 Latent proportional change model
Variance of y[t]n is decomposed into three parts: variance associated with one’s
true score at t-1 (y[t−1]n), variance associated with the true change (Δy[t]n) from t-1 to t,
and covariance between y[t−1]n and Δy[t]n.
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In the structural model, the mean and variance of the first latent true score (M1)
were freely estimated, but the means and variances of the subsequent latent true scores
(M2 and M3) were fixed at 0. The latent change scores (LCS21 and LCS32) were set to
have a mean and a variance of 0. The autoregressive coefficients were set to 1.
Intervention assignment was treated as a predictor of latent change scores. In the
measurement model, the latent construct of interest was measured using several
indicators (e.g., items 1-3). We assumed measurement invariance and correlated residual
errors over time. The overall model was depicted in Figure 3.6.
3.7.4 Missing data
Cases with missing data on outcome variables at any follow-up wave were
retained through the use of the full information maximum likelihood (FIML) estimator
which gives valid estimates when missing data are MCAR or missing at random (MAR)
(17). Complete-case analysis was conducted when data were missing on covariates.
3.7.5 Clustering
In the main analysis, a sandwich estimator of standard errors was used to account
for the clustered nature of data (patients were nested within clinics). In addition,
sensitivity analysis was conducted by applying the multi-level method (details in
Appendix A). Simply, the mean and the variance were decomposed into the within-clinic
level and the between-clinic level. The intervention was treated as a clinic-level covariate
in the analysis.
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Figure 3.6 Structural modeling for the proportional latent change score (LCS) model

CHAPTER 4
MANUSCRIPTS

4.1 INTERVENTION EFFECTS OF A THEORY-BASED PARENTAL HIV
DISCLOSURE INTERVENTION AMONG PARENTS LIVING WITH HIV (PLH) IN
CHINA --- APPLICATION OF THE HEALTH ACTION PROCESS APPROACH
(HAPA)1

1

Da, W., Li, X., Qiao, S. (2019). To be submitted to AIDS and Behavior.
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Abstract
With prolonged lives thanks to antiretroviral therapy, ongoing challenges are
faced by parents living with HIV (PLH) regarding telling their HIV-positive status to
children (i.e., parental HIV disclosure). To assist PLH in making a well-planned and
developmentally appropriate HIV disclosure to their uninfected children, a theory-driven
intervention was conducted among 791 PLH with children aged between 6-15 years in
Guangxi, China.
Using secondary data from the baseline (W1) and the first two follow-ups (W2 at
6-month and W3 at 12-month) data, intervention effect on HIV disclosure process was
evaluated. Three critical disclosure stages were defined based on the stage model of the
Health Action Process Approach (HAPA): 1) the pre-intention stage, in which people
have not yet decided to disclose; 2) the intention stage, in which people have decided to
disclose but have not yet started action; 3) the action stage, in which individuals make
actual disclosure event. Accordingly, people at the three stages were defined as preintenders, intenders, and actors.
A multigroup first-order manifest Markov Chain method was conducted to assess
the intervention effect on disclosure stage transitions between W2 and W3. Among preintenders at the first follow-up, those in the intervention group were more likely to
progress to the action stage rather than being static (OR = 3.43, 95% CI 1.17, 10.01).
However, no statistically significant intervention effect was detected in promoting
progression from pre-intention to intention (OR = 1.02, 95% CI 0.47, 2.20). Among
intenders at the first follow-up, no statistically significant intervention effect was detected
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in preventing backward transition to pre-intention (OR = 0.71, 95% CI 0.35, 1.43) or
promoting forward transition to action (OR = 2.01, 95% CI 0.84, 4.79).
Study findings suggest HIV disclosure can be modeled as a process with 3 stages
guided by HAPA. Also, the stage-specific intervention effects suggest PLH at different
stages may respond differently to the intervention. In order to develop stage-specific
interventions tailored to parents’ needs, better understanding in terms of key psychosocial
factors predicting HIV disclosure stage transitions is needed.
Introduction
By the end of 2017, there were 36.9 million people living with HIV (PLHIV)
worldwide, among which 21.7 million were receiving antiretroviral therapy (ART) (Joint
United Nations Programme on HIV/AIDS, 2018a). As reported on the 5th National
Conference on HIV/AIDS in China, there were 820,756 reported PLHIV in China by the
end of June 2018, among which 80.4% were receiving ART (China Center for Disease
Control and Prevention, 2018). With prolonged lives thanks to ART, parents living with
HIV (PLH) are more likely to raise their children to adolescence or even adulthood. The
2012 survey showed that among 2458 PLH, 1043 (42.1%) had more than one adult
children, and 1254 (50.6%) had at least one child between 5-16 years old.
For PLH, telling their HIV-positive status to children (i.e., parental HIV
disclosure) is challenging especially when it comes to younger children. According to the
China Stigma Index Report, less than half of PLH reported that their children were aware
of their HIV status (Institute of Social Development Research, 2009). An even lower rate
of 25% was found in the 2012 survey among 1254 PLH who had children between 5-16
years old (Qiao et al., 2015).
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In 2011, the World Health Organization (WHO) published the Guideline on HIV
Disclosure Counselling for Children Up to 12 Years of Age (World Health Organization,
2011). As there is evidence of mutual health benefits for both children and caregivers,
parental HIV disclosure is recommended to school-aged children. Noticeably, a 2013
systematic review of global literature on parental HIV disclosure reported mixed findings
regarding the impacts of disclosure on children (Qiao, Li, & Stanton, 2013). As argued by
the authors, a large number of parental disclosures were unintentional, poor-prepared, or
even forced. This suggests the desired benefits of parental HIV disclosure may only be
generated when it is culturally and developmentally appropriate and well-planned.
According to Omarzu et al., HIV disclosure is a cognitive process to determine
whether, when, and how to disclose (Omarzu, 2000). The first stage is about disclosure
intention formation and the next two stages are about preparation and planning for the
intention-to-action translation. In the HIV Disclosure Guide published by the HIV/AIDS
Resources & Community Health (ARCH) (HIV/AIDS Resources & Comunity Health,
2016), HIV disclosure is depicted as a process starting from diagnosis adjustment and
self-educating, moving into preparation and planning for disclosure, and finally
translating into disclosure action. Great emphasis was put on the preparation and
planning phases where patients create disclosure plans by setting disclosure goals,
deciding where, when, and how to disclose, as well as seeking disclosure support.
However, a dearth of interventions with aims to assist PLH with parental HIV
disclosure have focused on the stage of disclosure process in the impact evaluation
(Conserve et al., 2017). In the recent systematic review on parental HIV disclosure
interventions, all the included intervention studies used HIV disclosure action (event) as
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the primary outcome in the evaluation. Of these four intervention studies, two studies
assessed intervention effect on HIV disclosure action as a binary yes-or-no measure, one
study assessed intervention effect on disclosure as no disclosure, partial disclosure using
the word virus, and full disclosure using the word HIV, and one study assessed
intervention effect on disclosure as a 0-6 scale ranging in disclosure breadth (i.e., the
topics covered in the communication).
Considering the lack of studies viewing HIV disclosure decision-making as a
process, we borrowed the conceptualization posited by the Health Action Process
Approach (HAPA) stating that people pass through an ordered set of qualitatively
different stages to make behavior change (Weinstein et al., 1998). According to HAPA,
engagement in behavior change goes through the intention formation and the intention
translation processes. Briefly, there are three critical stages: 1) the pre-intention stage, in
which people have not yet decided to act; 2) the intention stage, in which people have
decided to act but have not yet started action; 3) the action stage, in which individuals
make actual behavior change (Schüz et al., 2008).
Given that the central outcomes in stage theories such as HAPA are stage
transitions, the current study focused on applying HAPA to evaluate intervention effects
on HIV disclosure stage transitions. The primary research questions addressed were: (1)
Does intervention condition affect specific stage transition probabilities; and (2) Does the
intervention influence the overall pattern of HIV disclosure stage transition (i.e.,
backward transition or forward transition)?
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Methods
a. Study setting
This intervention was conducted in Guangxi, one of the regions with the highest
prevalence of HIV in China. The HIV epidemic in Guangxi features a large number of
newly reported HIV/AIDS cases, as well as multiple modes of HIV transmission (e.g.,
drug use, same-sex behavior, commercial sex behavior)(Zheng et al., 2018).
The top two cities (urban centers) and the top eight rural counties with the largest
number of reported HIV/AIDS cases were selected among all 14 cities and 75 rural
counties to participate. Next, urban districts in the two cities and townships in the eight
rural counties with at least 200 HIV/AIDS cases were identified, and a total of 40 clinics
were randomly selected. To select participants, 20 PLH were randomly selected from
each of the 40 participating clinics.
Stratified cluster randomization was used to assign each clinic into either the
intervention or the control conditions. Briefly, all 40 clinics were first stratified into 10
strata (4 clinics/stratum) based on their similarities in the number of PLHIV served and
geographic locations (rural vs. urban). Within each stratum, two clinics were randomly
assigned to the intervention group and the other two were assigned to the control group.
Baseline survey and 6-waves of follow-ups (every 6 months) were conducted.
b. Study sample
Patients who have not disclosed their HIV infection to their seronegative children
aged between 6 to 15 years of age were recruited from the participating primary public
HIV clinics in the 40 districts/townships. Medical staff or case managers at HIV clinics
referred potential participants to local team members who visited each clinic twice a
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week during the recruitment period. If both father and mother in a family were eligible,
the mother or the healthier parent was invited to participate. The project protocol was
approved by the Institutional Review Boards (IRB) at Guangxi CDC in China and Wayne
State University in the United States. All participants provided written informed consent.
c. Description of intervention
1. Intervention contents
Intervention group
Three main components (child development, illness communication, and coping)
were included for the intervention group. Child development focused on understanding
the stages of childhood cognitive development in the context of parental illness and
assessing the child’s readiness for disclosure. Illness communication focused on
improving the parents’ cognitive (benefits and risks of disclosure, disclosure is an
ongoing process) and behavioral skills (how to tell and what to tell) related to parental
HIV disclosure. Coping focused on improving parental psychosocial well-being in
adapting to living with HIV/AIDS.
Control group
The control group received nutrition education modeled after the “Simply Good
Eating” curriculum (Sherman et al., 2012) and modified in accordance with current
“Dietary Guidelines for Chinese Residents” (Ge et al., 2008). The modified curriculum
aims to increase parents’ knowledge of nutrition, healthy diets and cooking practice, and
food safety.
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2. Intervention delivery
A two-hour session was delivered every week for five weeks in the clinics where
the parents were recruited. At each clinic, two trained facilitators delivered the materials
through discussions, role-play, exercise, and/or games.
3. Data collection
The baseline and a total of six-month follow-up surveys were administered to the
parents in a private room (e.g., doctor’s office) at district/township hospitals where these
parents were recruited. The interviewer read each question in the questionnaire, and the
participant gave an oral response to each question. Clarifications were provided when
needed.
d. Measures
1. HIV disclosure stage
Participants’ HIV disclosure stage was measured using one question with 6 points:
1 = “having not started disclosure in the past 6 months and no intention to start”, 2 =
“having not started disclosure in the past 6 months but is intending to start”, 3 = “having
not started disclosure in the past 6 months but already made a plan”, 4 = “started
disclosing but not mentioning HIV”, 5 = “started disclosing with the word HIV”, and 6 =
“started disclosing with the word HIV and how I got infected”.
The original 6 categories were collapsed into pre-intenders (response 1), intenders
(responses 2-3), and actors (responses 4-6) based on the 3-stage HAPA (Schüz et al.,
2008). These three stages of HIV disclosure were used in further analysis of intervention
effects.
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2. Baseline characteristics
Parents’ demographics (age, gender, marital status, level of education) and HIVrelated characteristics (route of infection, and time since diagnosis, antiretroviral therapy
uptake, CD4 count, viral load) were collected at baseline. Children’s gender and age
group (6-9 years, 10-12 years, and 13-16years) were also collected.
Analysis
The baseline (W1) and two follow-ups (W2 at 6-month and W3 at 12-month) data
were used for this study. The analysis was conducted using Stata 13.0 (College Station,
TX) and Mplus 7.4 (Muthen & Muthen). Somers' D was calculated to compare the
distribution of HIV disclosure stage between the intervention and the control groups at
W2 and W3.
Intervention effect on HIV disclosure stage was examined using a first-order
manifest Markov model by assuming that 1) the stage occupied at W3 depends only on
the stage occupied at W2, not W1 (i.e., first-order); and 2) there was no measurement
error in the stages (i.e., manifest). Details of the model can be found in Chapter 3, session
3.7.3. Briefly, two regressions were conducted --- one for the stage membership at W2
(U1) and one for the stage transition between W2 and W3 (U2). A multinomial logistic
regression was conducted to model stage membership at W2. Conditional multinomial
logistic regressions were conducted to model stage membership at W3 given a certain
W2 stage membership.
In terms of stage membership, no restriction was made on stage membership at
W2. An absorbing stage of actors (e.g., no one could move out of this class) was defined
by imposing parameter restrictions on backsliding from action to earlier stages.
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Therefore, six possible transition patterns were modeled: static at pre-intention, forward
transition from pre-intention to intention, forward transition from pre-intention to action,
static at intention, backward transition from intention to pre-intention, and forward
transition from intention to action.
To test the equivalence of stage membership at W2 by intervention arms, the
intervention arm was treated as a covariate. To test for the equality of transition matrix by
intervention group, comparison of model fit was made between a model allowing
different group-specific transition patterns (Model 1) and a model with a constraint on
equal transition matrix across intervention arms (Model 2). Model fit was compared
using log-likelihood ratio G2 difference tests (L. M. Collins, Fidler, Wugalter, & Long,
1993). The Akaike Information Criteria (AIC) and the Bayesian Information Criteria
(BIC) were also used. The entropy of models was also considered.
In order to produce a broader picture of intervention effect on transition
probabilities, unsuccessful and successful stage transitions were further defined. For preintenders, forward transition to either the intention or the action stage was defined as
“successful”, whereas no change was defined as “unsuccessful”. For intenders, a
backward transition to the pre-intenders was defined as “unsuccessful”, whereas no
change or forward transition to the action stage was defined as “successful”. Different
categorization of the “no change” group was based on the fact that HIV disclosure
preparation and planning can take much longer than 6 months. A study conducted among
HIV-positive parents found that most “take years to prepare for disclosure, proceeding
when they judge themselves ready to impart the news and their children receptive to
receive the news” (Gachanja, Burkholder, & Ferraro, 2014b).
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Further, the baseline covariates influencing stage membership at W2 were
included. These covariates were selected a priori (European Medicines Agency, 2015).
As suggested by Streiner, “the ideal covariates are those that are related to intrinsic
properties of the participants, such as age or sex, or are measured before the
randomization” (Streiner, 2016). Moreover, according to the guideline on adjustment for
baseline covariates in clinical trials, “the clinical and statistical relevance of a covariate
should be assessed and justified from a source other than the current dataset” (Committee
for Medicinal Products for Human Use, 2015). Therefore, Individual prognostic
covariates were selected based on 1) previous observational studies conducted among
PLHIV in Guangxi, China; 2) previous literature review regarding correlates of parental
HIV disclosure (Adeoye-Agboola, Evans, Hewson, & Pappas, 2016; Hawk, 2007;
Rochat, Stein, Cortina-Borja, Tanser, & Bland, 2017). Parent-level variables included
parents’ age, gender, marital status, route of infection, and CD4 count. Child-level
variables included gender and age group (6-9 years, 10-12 years, and 13-16years).
Collinearity of individual-level covariates was checked using the variance inflation
factors (VIF).
The full information maximum likelihood (FIML) estimator was used to retain
cases with missing data at either wave. It gives valid estimates when missing data are
MCAR or missing at random (MAR) (Enders & Bandalos, 2001). Complete-case analysis
was conducted for missing covariates. A sandwich estimator of standard errors was used
to account for the clustered nature of data (patients were nested within clinics). Random
start values were used to ensure that the models converge on global, rather than local
solutions (Peel & McLachlan, 2000).
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Results
A CONSORT flow diagram was shown in Figure 4.1. Among all 791 who
completed the baseline survey, participants who did not respond to the HIV disclosure
question at both W2 and W3 were excluded from further data analysis. In total, 374
participants from the intervention group and 377 participants from the control group were
included in the final analysis.
Enrollment
Randomized (n= 40 clusters
and 791 patients)

Allocation
Allocated to intervention (n= 20
clusters, 388 patients)

Allocated to intervention (n= 20
clusters, 403 patients)

Follow-up
Lost to follow-up at W2 (n= 17)
Lost to follow-up at W3 (n= 17)

Lost to follow-up at W2 (n= 36)
Lost to follow-up at W3 (n= 37)

Analysed (n= 377)
¨ Excluded from analysis (no
outcome measure at both W2 and
W3) (n= 26)

Analysis
Analysed (n= 374)
¨ Excluded from analysis (no
outcome measure at both W2 and
W3) (n= 14)

Figure 4.1 CONSORT flow diagram of 791 participants
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The distribution of baseline covariates by intervention group was shown in Table
4.1. A total of 791 participants completed the baseline survey. The average age was 37.7
years old, most participants were males (57.5%) and married (76.5%). Nearly half of the
participants had only completed primary school education (46.5%). Around half of the
participants were full-time employed (46.8%), and most had a monthly income of less
than 1000 RMB (54.2%). More than a third (35.3%) were infected by their main
partner/spouse, and nearly one fourth (23.9%) had a CD4 count greater than 500
copies/ml. For children, around half were between 6 to 9 years old (47.7%), and most
were boys (53.0%). No statistically significant differences were detected in the
randomization check or the attrition analysis.
Table 4.1 Baseline characteristics by intervention status

Variables
Parent level
Socio-demographics
Age
Gender
Male
Female
Marital status
Married
Separated/divorced
Widowed
Education completed
Primary school
Middle school
High school and higher
Employment
Unemployed
Part-time
Full-time
Income
0-999

Intervention
N = 403

Control
N = 388

Total
N = 791

37.6±5.7

37.8±5.4

37.7±5.6

231(57.3)
172(42.7)

224(57.7)
164(42.3)

455(57.5)
336(42.5)

303(75.4)
41(10.2)
58(14.4)

301(77.6)
41(10.6)
46(11.9)

604(76.5)
82(10.4)
104(13.2)

169(43.0)
195(49.6)
29(7.4)

186(50.3)
156(42.2)
28(7.6)

355(46.5)
351(46.0)
57(7.5)

97(24.1)
131(32.6)
174(43.3)

58(15.2)
131(34.3)
193(50.5)

155(19.8)
262(33.4)
367(46.8)

20(57.1)

199(51.3)

429(54.2)

52

Variables
1000-1999
≥2000
Clinical-related factors
Route of infection
Spouse/main partner
Commercial sex
IDU
Others
CD4 group
<200
200-349
350-500
≥500
Child-level
Age group
6-9
10-12
13-18
Gender
Male
Female

Intervention
N = 403
125(31.0)
48(11.9)

Control
N = 388
130(33.5)
59(15.2)

Total
N = 791
255(32.2)
107(13.5)

144(35.7)
121(30.0)
58(14.4)
80(19.9)

135(34.8)
143(36.9)
49(12.6)
61(15.7)

279(35.3)
264(33.4)
107(13.5)
141(17.8)

77(19.5)
121(30.6)
99(25.1)
98(24.8)

69(18.8)
117(31.8)
98(26.6)
84(22.8)

146(19.1)
238(31.2)
197(25.8)
182(23.9)

199(49.3)
110(27.2)
95(23.5)

172(46.0)
86(23.0)
116(31.0)

371(47.7)
196(25.2)
211(27.1)

209(54.1)
177(45.9)

185(51.8)
172(48.2)

394(53.0)
349(47.0)

Descriptive analysis of HIV disclosure stage
Distribution of HIV disclosure stage at W2 and W3 by intervention group was
shown in Table 4.2. Somers’ D statistics suggested a statistically significant difference in
HIV disclosure stage by intervention group at W3, but not W2.
Table 4.2 Distribution of HIV disclosure stage at W2 and W3 by intervention group

Study
wave
W2
W3

Intervention
HIV disclosure stage
group
PreIntention
Action
intention
Intervention 173(46.8)
133(36.0)
64(17.3)
Control
179(48.1)
134(36.0)
59(15.9)
Intervention 170(46.1)
127(34.4)
72(19.5)
Control
200(54.6)
129(35.3)
37(10.1)
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Total
370(100.0)
372(100.0)
369(100.0)
366(100.0)

Somers'
D
0.019, p =
0.628
0.12, p =
0.002

Intervention specific stage movement patterns
Model fit statistics were shown in Table 4.3. A statistically significant difference
in 𝐺 2 was detected, suggesting that the unrestrained Model 1 was favored over the
restrained Model 2 (p = 0.021). Therefore, unrestrained Model 1 was selected for further
analysis. The chi-square test for MCAR showed no statistically significant effect (p =
0.85), suggesting that the assumption of MCAR was met. The entropy was 0.95,
suggesting a good model fit.
Table 4.3 Model fit comparing the unrestrained Model 1 with the restrained Model 2

𝑮𝟐

H0 value
ℓ
Model 1
5290.58 -2645.29
Model 2
5302.09 -2651.04
Difference 11.51

No. of free
parameters (p)
13
9
4

Df = W – P 1
4
8
p = 0.021

AIC

BIC

5316.58 5376.66
5320.09 5361.68

The transition probabilities were shown in Figure 4.2. The probability of staying
in a given stage is represented by a circle and the probability of transition is represented
by either solid (for forward movement) or dashed (for backward movement) arrows. In
the control group, among pre-intenders at W2, 78.3% stayed static at W3, 19.4%
progressed to the intention stage, and only 2.3% progressed to the action stage. Among
intenders at W2, 34.2% regressed to the pre-intention stage at W3, 57.7% stayed static,
and 8.1% progressed to the action stage.
In the intervention group, among pre-intenders at W2, 74.1% stayed static at W3,
18.7% progressed to the intention stage, and only 7.3% progressed to the action stage.
Among intenders at W2, 24.7% regressed to the pre-intention stage at W3, 58.8% stayed
static, and 16.6% progressed to the action stage.
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Control
0.023
0.081

0.194
Intention
0.577

Pre-intention
0.783

Action

0.342

0.073

Intervention

0.166

0.187
Intention
0.588

Pre-intention
0.741

Action

0.247

Figure 4.2 Estimated transition probabilities by intervention groups
Intervention effects on HIV disclosure stage membership at W2 and stage transition
Intervention effects on stage membership were shown in Table 4.4. No
statistically significant difference was detected for either pre-intenders (OR = 1.37, 95%
CI 0.66, 2.84) or intenders (OR = 1.36, 95% CI 0.74, 2.48). Similar results were found
after adjusting for baseline covariates, with the ORs being 1.45 (95% CI 0.66, 3.19) for
pre-intenders and 1.53 (95% CI 0.79, 2.97) for intenders.
Table 4.4 Intervention effect on W2 stage membership

W2 stage membership
Unadjusted model
Pre-intention

Odds ratio

95% CI

P-value

1.37

0.66, 2.84

0.483
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W2 stage membership
Intention
Action (ref)
Adjusted model
Pre-intention
Intention
Action (ref)

Odds ratio
1.36

95% CI
0.74, 2.48

P-value
0.401

1.45
1.53

0.66, 3.19
0.79, 2.97

0.432
0.289

Intervention effects on stage transition were shown in Table 4.5. Among preintenders at W2, those in the intervention group were more likely to progress to the action
stage rather than being static (OR = 3.43, 95% CI 1.17, 10.01). However, no statistically
significant intervention effect was detected in promoting progression from pre-intention
to intention (OR = 1.02, 95% CI 0.47, 2.20). Overall, no statistically significant
intervention effect was detected in promoting a successful transition. Among intenders at
W2, no statistically significant intervention effect was detected in preventing backward
transition to pre-intention (OR = 0.71, 95% CI 0.35, 1.43), promoting forward transition
to action (OR = 2.01, 95% CI 0.84, 4.79), or promoting overall successful transition (OR
= 1.59, 95% CI 0.82, 3.09). Similar results were detected after adjusting for covariates.
Table 4.5 Intervention effects on stage transition

W2 stage

W3 stage
Intention

Action

1.02(0.47, 2.20)

3.43(1.17, 10.01)

Ref

2.01(0.84, 4.79)

Adjusted model
Pre-intention Ref

1.07(0.49, 2.35)

6.66(1.72, 25.8)

Intention

Ref

1.81(0.74, 4.45)

Pre-intention
Unadjusted model
Pre-intention Ref
Intention

0.71(0.35, 1.43)

0.69(0.33, 1.40)
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Successful
transition
1.27(0.59,
2.71)
1.59(0.82,
3.09)
1.42(0.65,
3.13)
1.60(0.80,
3.18)

Discussion:
This is one of the first efforts applying the HAPA in the evaluation of parental
HIV disclosure interventions. Our results showed that the theory-based intervention
yielded different effects when targeting PLHIV at different initial stages of HIV
disclosure. Specifically, pre-intenders responded most to the intervention with higher
odds of transition into action rather than staying at the pre-intention stage. However, for
intenders, no statistically significant intervention effect was detected.
Interestingly, our results showed that stage sequential change does not necessarily
occur in a linear fashion as a small number of patients were found to skip stages out of
the sequential order. Specifically, such pre-intenders skipped the intention stage and went
directly to the action stage within the 6 months. One possible explanation, as mentioned
earlier, was the measurement error which has the highest impact on the smallest response
category (i.e., the pre-intenders) (Bassi, Hagenaars, Croon, & Vermunt, 2000). Another
explanation was that the time window of 6 months was too wide to capture their
sequential change. However, as mentioned earlier, it may take years before the intention
is transformed into action. Further studies comparing the transition structure models with
and without constraints on forward transition from pre-intention to action may help better
understand whether such abrupt transition is possible. Moreover, if patients did actually
make an abrupt transition without detailed planning and preparation, more studies are
needed to disentangle predictors of such stage skipping and its corresponding
consequences.
Mixed findings have been reported regarding the efficacy of previous parental
HIV disclosure interventions (Conserve et al., 2017). For example, Rotheram-Borus et al.
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found no statistically significant difference in the presence or absence of parental HIV
disclosure across conditions over 24 months. However, a previous parental HIV
disclosure intervention conducted among PLH in Shanghai, China was found to promote
movement along the disclosure behavior continuum as soon as 4 weeks after intervention.
Noticeably, the Shanghai intervention was conducted among patients with teenage or
adult children. The parental HIV disclosure literature showed that disclosure rates were
higher among parents with older children compared to younger school-aged children.
Moreover, if we look at the changes in the mean score of the 7-point disclosure behavior
continuum, the intervention promoted participants’ movement from 1 (i.e., giving general
information about HIV) to 3 (i.e., disclosing having a specific disease but not HIV).
Therefore, such movement may suggest more of an increase in parent-child
communication rather than the disclosure process posited in this study.
The lack of intervention effect on the intention to action transition may also be
explained by the variation of children’s age in our study. As mentioned earlier, around
half of children were between 6 to 9 years old (47.7%), 25.2% were between 9-12 years
old, and 27.1% were between 13-16years old. Previous studies have found a lower
disclosure rate among parents with younger children as they were considered as “too
young to understand”. However, age-appropriate disclosure for young children may not
cover stigmatized and sensitive questions such as the route of infection, which has been
identified as a key barrier for parental HIV disclosure. However, we were unable to test
the moderating effect of child age due to the limited sample size.
Several limitations exist in this study which may influence the interpretation of
our findings. First, we assumed no measurement error regarding HIV disclosure stage.
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However, theoretically impossible backward stage transition out of the action stage was
observed in this study. To cope with such measurement error, more complicated latent
Markov models estimating the item-response probabilities can be used. Second, child age
has been identified as one of the most consistent and influential predictor of parental HIV
disclosure (Qiao et al., 2013). As child age increases, the incidence of parental HIV
disclosure increases significantly. However, we were unable to test the moderating effect
of child age due to the limited sample size.
Despite these limitations, this study has significant implications for future studies.
First, the 3-stage HAPA model can be applied to the evaluation of HIV disclosure
interventions yet more complicated models such as the mover-stayer latent transition
analysis need to be explored. Second, when assessing the intervention effects on stage
transition, consideration of both specific transition probabilities and overall forward or
backward transition patterns enables a more comprehensive interpretation of intervention
effects. Third, the stage-specific intervention effects detected in this study indicate the
need for stage-specific interventions which may be more effective in promoting stage
transitions. To develop such tailored interventions, a better understanding of different
predictors for each specific stage transition is warranted. Therefore, further mediation
analysis exploring the mediating effects of such predictors on HIV disclosure stage
transitions may help us elucidate the mechanism causing HIV disclosure stage transitions.
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4.2 PSYCHOSOCIAL FACTORS PREDICTING TRANSITIONS IN HIV DISCLOSURE
STAGES --- EVALUATION OF A THEORY-BASED PARENTAL HIV DISCLOSURE
INTERVENTION AMONG PARENTS LIVING WITH HIV IN CHINA1

1

Da, W., Li, X., Qiao, S. (2019). To be submitted to AIDS and Behavior.
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Abstract
Several key psychosocial factors such as outcome expectancy and self-efficacy
have been identified to influence HIV disclosure. However, when operationalized as a
process with 3 stages according to the Health Action Process Approach (HAPA), the
potential stage-specific roles of psychosocial factors on HIV disclosure stage transition
have not been well studied.
Using secondary data from a theory-based parental HIV disclosure intervention
conducted among parents living with HIV in China, 2012, intervention effects on
psychosocial factors such a parental HIV disclosure knowledge, disclosure outcome
expectancy measured by perceived costs and rewards, disclosure action self-efficacy, and
disclosure action planning were evaluated. Moreover, the predictive effects of such
factors on HIV disclosure stage transition was examined.
Guided by the stage model of the Health Action Process Approach (HAPA), three
critical disclosure stages were defined: 1) the pre-intention stage, in which people have
not yet decided to disclose; 2) the intention stage, in which people have decided to
disclose but have not yet started action; 3) the action stage, in which individuals make
actual disclosure event. A latent change score (LCS) method was used to assess the
intervention effect on disclosure-related psychosocial factors including knowledge,
outcome expectancy (perceived costs and rewards), self-efficacy, and planning.
Predictive effects of these psychosocial factors on disclosure stage transitions were
examined by treating these factors as covariates in a Markov chain model estimating HIV
disclosure stage transition matrix.
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At the first follow-up, statistically significant intervention effect was detected for
disclosure knowledge (β=0.137, 95% CI 0.037-0.237, p=0.007), action self-efficacy (β =
0.277, 95% CI 0.120, 0.434, p=0.001), and action planning (β = 0.344, 95% CI 0.168,
0.519, p<0.001) but not for disclosure outcome expectancy. Stage-specific predictive
effects of action self-efficacy and action planning on HIV disclosure stage transitions
were detected. Specifically, the progression from pre-intention to intention was promoted
by action self-efficacy and action planning, and regression from intention to pre-intention
was prevented by action planning.
The identification of stage-specific psychosocial predictors of stage transition
allows matching future interventions to psychologically defined HIV disclosure stages.
Introduction
As reported on the 5th National Conference on HIV/AIDS in China, there were
820,756 reported PLHIV in China by the end of June 2018, among which 80.4% were
receiving ART (China Center for Disease Control and Prevention, 2018). The 2019
UNAIDS special analysis reported that 83% of PLH who know their status have received
the treatment, and 94% have suppressed viral loads (Joint United Nations Programme on
HIV/AIDS, 2019). With prolonged lives thanks to ART, PLH face ongoing challenges
regarding telling their HIV-positive status to children (i.e., parental HIV disclosure).
According to the Disclosure Decision-Making Model (DDMM), parents assess
the rewards and costs for HIV disclosure (i.e., outcome expectancy) and a decision to
disclosure is made only when the rewards outweigh the costs (Chaudoir & Fisher, 2010).
Also, parents evaluate their ability to disclosure (i.e., disclosure self-efficacy) in the
decision-making process. The likelihood of disclosure increases as the rewards and selfefficacy increase and the costs decrease.
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Such a linear relationship between psychosocial predictors and the likelihood of
target behavior corresponds to the continuum model of behavior change (Lippke &
Ziegelmann, 2008). In contrast, stage models of behavior change posit that people pass
through qualitatively distinct, ordered phases during the process of behavior change
(Weinstein et al., 1998). Therefore, the HIV disclosure process, according to the Health
Action Process Approach (HAPA), can be measured with three critical stages: 1) the preintention stage, in which people have not yet decided to disclose; 2) the intention stage, in
which people have decided to disclose but have not yet started action; 3) the action stage,
in which individuals make actual disclosure action (Schwarzer, Lippke, & Luszczynska,
2011).
Moreover, such stages are characterized by similarities within stages and
psychological differences between stages (Schüz et al., 2008). Theoretically, preintenders will show lower perceived rewards and self-efficacy but higher perceived costs
than intenders. Intenders will show lower self-efficacy than actors, but no differences in
perceived costs or rewards are expected. Therefore, for pre-intenders, higher levels of
perceived rewards and self-efficacy, as well as lower levels of perceived costs, would
promote stage progression. For intenders, higher levels of self-efficacy would promote
stage progression, while lower levels of costs and higher levels of rewards would prevent
stage regression.
As emphasized by HAPA, as people pass different stages to make behavior
change, self-efficacy should be differentiated by the stages of change (i.e., intentionformation, behavior initiation, and behavior maintenance) (Schwarzer et al., 2003). In the
early pre-actional phase of behavior change, action self-efficacy plays a key role. People
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with high action self-efficacy “imagine success, anticipate potential outcomes of diverse
strategies, and are more likely to initiate a new behavior”. On the contrary, people with
low action self-efficacy “imagine failure, harbor self-doubts, and tend to procrastinate”
(Schwarzer, 2011).
Noticeably, the HAPA posits that planning precedes the initiation of behavior
change action. By planning, people first imagine a suitable future situation (“when” and
“where”) for behavior change. A specific behavioral action (“how”) is expected to be
effective for the intention to be translated into action in that situation. Among intenders,
those who form action plans may be more likely to translate their intentions into action.
Specifically, for HIV disclosure, patients create disclosure plans by setting disclosure
goals, deciding where, when, and how to disclose, as well as seeking disclosure support
(HIV/AIDS Resources & Comunity Health, 2016).
Although previous studies have included psychosocial factors in program
evaluation of parental HIV disclosure interventions, as no stage model was used to
operationalize HIV disclosure, their roles in disclosure stage transition have not been well
studied. The purposes of the present study are 1) to assess intervention effects on
psychosocial factors, and 2) to assess the predictive effects of psychosocial factors on
parental HIV disclosure stage transition. The main hypotheses of the study are outlined
in Table 4.6. Briefly, knowledge, outcome expectancy (costs and rewards), and action
self-efficacy were hypothesized to influence 1) the progression from pre-intention; and 2)
the regression from intention. Action planning was hypothesized to influence the
progression from intention.
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Table 4.6 Hypothesis of stage-specific psychosocial predictors

Stage
Pre-intention

Transition
Progression

Predictors
Knowledge (+)
Perceived costs (-)
Perceived rewards (+)
Action self-efficacy (+)

Non-significant factors
Action planning

Intention

Progression

Action planning (+)

Knowledge
Perceived costs
Perceived rewards
Action self-efficacy

Regression

Knowledge (-)
Action planning
Perceived costs (+)
Perceived rewards (-)
Action self-efficacy (-)
(+) indicates high levels of the predictor and (-) indicates low levels of the predictor

Methods
Study setting and study sample
This intervention was conducted in Guangxi, a southwest region ranked 3rd in
terms of HIV prevalence in China. The top two cities (urban centers) and the top eight
rural counties with the largest number of reported HIV/AIDS cases were selected as
study sites. Within the 10 cities/counties, urban districts or rural with at least 200
HIV/AIDS cases were identified, among which a total of 40 clinics were randomly
selected. Within each clinic, 20 PLH who have not disclosed their HIV infection to their
seronegative children aged between 6 to 15 years of age were randomly selected. Cluster
randomization was used to assign each clinic into either the intervention or the control
conditions. Baseline survey and 6-waves of follow-ups (every 6 months) were conducted.
The project protocol was approved by the Institutional Review Boards (IRB) at Guangxi
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CDC in China and Wayne State University in the United States. All participants provided
written informed consent.
Description of intervention
The intervention group received five 2-hour interactive training sessions with
three specific components: child development, illness communication, and coping.
Details of the components were summarized in Table 4.7. The control group received
five 2-hour sessions of nutrition education curriculum. The nutrition curriculum was
modeled after the “Simply Good Eating” curriculum (Sherman et al., 2012) and modified
in accordance with current “Dietary Guidelines for Chinese Residents” (Ge et al., 2008).
Table 4.7 Intervention components and corresponding sessions

Intervention components

Intervention sessions

Understanding the stages of childhood
cognitive development in the context of
parental illness

Session #1
“Child’s readiness for disclosure”

Improving the parents’ cognitive and
behavioral skills related to parental HIV
disclosure

Session #2
“Benefits and risks of disclosure”
Session #3
“How to tell and what to tell”
Session #4
“Disclosure is an ongoing

Improving parental psychosocial wellbeing in adapting to living with HIV/AIDS

Session #5
“Cope with my infection/illness”

Intervention delivery and data collection
Within each clinic, two trained facilitators delivered the materials through
discussions, role-play, exercise, and/or games (for group sessions). The five two-hour
parent intervention and control sessions were delivered one session per week for five
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weeks in the clinics where the parents are recruited. Two trained interviewers
administered the baseline and all six-month follow-up surveys to the parents in a private
room (e.g., doctor’s office). Participants completed the baseline survey before
intervention and 6 waves of follow-ups were conducted every 6 months.
Measures
1. HIV disclosure stage
One question was asked at both follow-ups to capture individual’s level of HIV
disclosure: 1 = “having not started disclosure in the past 6 months and no intention to
start”, 2 = “having not started disclosure in the past 6 months but is intending to start”, 3
= “having not started disclosure in the past 6 months but already made a plan”, 4 =
“started disclosing but not mentioning HIV”, 5 = “started disclosing with the word HIV”,
and 6 = “started disclosing with the word HIV and how I got infected”.
Based on the stage model of HAPA, the original 6 categories were collapsed into
pre-intenders (response 1), intenders (responses 2-3), and actors (responses 4-6). These
three stages of HIV disclosure were used in further analysis.
2. Psychosocial factors
Disclosure outcome expectancy was measured by the perceived costs and rewards
of parental HIV disclosure. Disclosure costs were measured with 4 questions (e.g., “do
you agree that disclosing to children will impact their academic performance?”), and
disclosure rewards were measured with 5 questions (e.g. “do you agree that children will
provide more support after knowing your status?”). Responses ranged from 1 =
“completely disagree” to 4 = “completely agree”.
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As the perceived costs and rewards depend on patients’ understanding of parental
HIV disclosure, participants were also assessed on their knowledge regarding parental
HIV disclosure using an author derived scale with 5 questions (e.g. “do you agree that
parental HIV disclosure should take children’s developmental stage into consideration”).
Responses ranged from 1 = “completely disagree” to 4 = “completely agree”.
Action self-efficacy regarding parental HIV disclosure was measured with an
author derived scale with 9 questions. Sample questions are “how confident are you that
you can make a parental HIV disclosure plan?” and “how confident are you that you can
talk with children about basic HIV/AIDS knowledge?”. Responses ranged from 1 =
“completely unconfident” to 5 = “completely confident”.
Action planning regarding parental HIV disclosure was measured with an author
derived scale with 9 questions. Three general questions regarding when, who, and how to
disclose and 6 specific questions (e.g., “how to explain what HIV is”, “how to deal with
children’s reaction”) were asked. Responses were 1 = “will never consider”, 2 = “have
not considered yet”, 3 = “considering”, and 4 = “already planned”.
3. Baseline characteristics
Parent-level variables include parents’ demographics (age, gender, marital status,
level of education) and HIV-related variables (route of infection, and time since
diagnosis, antiretroviral therapy uptake, CD4 count, viral load). Child-level variables
include gender and age group (6-9 years, 10-12 years, and 13-16years).
Analysis
Only baseline (Wave 1 or W1), 6-month follow-up (Wave 2 or W2), and 12month follow-up (Wave 3 or W3) data were used in this paper. All analysis was
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conducted in Mplus 7.4 (Muthen & Muthen). A proportional latent change score (LCS)
method was used to evaluate intervention effect on psychosocial factors. Simply, the
predicted changes are proportional to the state (or status) of the prior true score.
Intervention assignment was treated as a predictor of latent change scores. In the
measurement model, the latent construct of interest was measured using the observed
items for each psychosocial variable. We assumed measurement invariance and
correlated residual errors over time. Details of the model were depicted in Figure 4.3.
In order to use information from cases with only baseline or only follow-up valid
values in estimating the model parameters, the Full Information Maximum Likelihood
(FIML) method was used. Robust (sandwich) variance estimator was used to account for
clinic-level correlation, and potential baseline confounders were included.
To assess whether psychosocial factors at W2 can predict stage transitions
between W2 and W3, we first modeled the stage transition matrix. Details of the model
specification can be found in manuscript 4.1. As backward transition from the action
stage is not theoretically possible, six stage-specific transition patterns were modeled
(Figure 4.4): static at pre-intention (A1), forward transition from pre-intention to
intention (A2), forward transition from pre-intention to action (A3), static at pre-intention
(B1), backward transition from intention to pre-intention (B2), and forward transition
from intention to action (B3).
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Intervention

Observed variable

Latent variable

Directed relationship (e.g., factor
loadings, regressions)

Constant (e.g., mean,
intercept)
Undirected relationship (e.g.,
variance, error)

Figure 4.3 Structural modeling setup for the proportional latent change score (LCS) model

A3

B3

A2
Intention
B1

Pre-intention
A1

Action

B2

Figure 4.4 Possible stage transition patterns
Second, the predictive effect of the proposed psychosocial factor at W2 on HIV
disclosure stage transition was tested by including the estimated value at W2 based on the
LCS model as a covariate for stage-specific transition probabilities. Intervention
assignment was also included as a covariate for stage-specific transition probabilities.
Parents’ age and gender, as well as the child’s age group and gender, were included as
covariates influencing stage membership at W2 and W3. Details of the conditional
multinomial logistic regression can be found in Table 4.8.
Table 4.8 Predictive effect of psychosocial factors on stage transition

U2
1
2
3
U1 1 b11+g11*Intervention+h11*M2
b21+g21* Intervention+h21*M2
0
2 b12+g12*Intervention+h12*M2
b22+g22* Intervention+h22*M2
0
3 0
0
0
Note: The b parameters are slopes for the multinomial regression of U2 on U1. The g
parameters are slopes for the intervention. The h parameters are slopes for the estimated
value of psychosocial factors at W2 based on the LCS model.
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Results
Baseline characteristics by intervention group were shown in Table 4.9. Among
all 791 participants who completed the baseline survey, the average age was 37.7 years
old. Most were males (57.5%) and married (76.5%). Around half of participants had only
completed primary school education (46.5%) and full-time employed (46.8%). More than
half had a monthly income of less than 1000 RMB (54.2%). More than a third were
infected by their main partner/spouse (35.3%), and less than one fourth had a CD4 count
greater than 500 copies/ml 23.9%). Around half of the children were between 6 to 9 years
old (47.7%), and most were boys (53.0%).
Table 4.9 Baseline characteristics by intervention status

Variables
Parent level
Socio-demographics
Age
Gender
Male
Female
Marital status
Married
Separated/divorced
Widowed
Education
completed
Primary school
Middle school
High school and
higher
Employment
Unemployed
Part-time
Full-time
Income
0-999

Intervention
N = 403

Control
N = 388

Total
N = 791

37.6±5.7

37.8±5.4

37.7±5.6

231(57.3)
172(42.7)

224(57.7)
164(42.3)

455(57.5)
336(42.5)

303(75.4)
41(10.2)
58(14.4)

301(77.6)
41(10.6)
46(11.9)

604(76.5)
82(10.4)
104(13.2)

169(43.0)
195(49.6)
29(7.4)

186(50.3)
156(42.2)
28(7.6)

355(46.5)
351(46.0)
57(7.5)

97(24.1)
131(32.6)
174(43.3)

58(15.2)
131(34.3)
193(50.5)

155(19.8)
262(33.4)
367(46.8)

20(57.1)

199(51.3)

429(54.2)
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Variables
1000-1999
≥2000
Clinical-related
Route of infection
Spouse/main
partner
Commercial sex
IDU
Others
CD4 group
<200
200-349
350-500
≥500
Child-level
Age group
6-9
10-12
13-18
Gender
Male
Female

Intervention
N = 403
125(31.0)
48(11.9)

Control
N = 388
130(33.5)
59(15.2)

Total
N = 791
255(32.2)
107(13.5)

144(35.7)

135(34.8)

279(35.3)

121(30.0)
58(14.4)
80(19.9)

143(36.9)
49(12.6)
61(15.7)

264(33.4)
107(13.5)
141(17.8)

77(19.5)
121(30.6)
99(25.1)
98(24.8)

69(18.8)
117(31.8)
98(26.6)
84(22.8)

146(19.1)
238(31.2)
197(25.8)
182(23.9)

199(49.3)
110(27.2)
95(23.5)

172(46.0)
86(23.0)
116(31.0)

371(47.7)
196(25.2)
211(27.1)

209(54.1)
177(45.9)

185(51.8)
172(48.2)

394(53.0)
349(47.0)

Intervention effects on psychosocial factors
High internal consistency was observed for all five scales at both baseline and two
follow-ups (Cronbach’s alpha 0.80 to 0.97). For parental HIV disclosure knowledge,
statistically significant intervention effect was detected for change between W2 and
baseline (β = 0.137, 95% CI 0.037, 0.237, p = 0.007), while no change was detected
between W2 and W3 (β = -0.002, 95% CI -0.119, 0.115, p = 0.555). Regarding outcome
expectancy, no statistically significant intervention effect was detected either for
disclosure rewards or costs. Statistically significant intervention effect was detected for
parental HIV disclosure self-efficacy between baseline and W2 (β = 0.277, 95% CI
0.120, 0.434, p=0.001), but not between W2 and W3 (β = 0.057, 95% CI -0.135, 0.249, p
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= 0.560). The intervention improved disclosure action planning both from baseline and
W2 (β = 0.344, 95% CI 0.168, 0.519, p<0.001) and between W2 and W3 (β = 0.140, 95%
CI 0.003, 0.277, p=0.045). Detailed results were shown in Table 4.10.
Table 4.10 Intervention effects on psychosocial factors

W1 to W2
Knowledge
Rewards
Costs
Action self-efficacy
Action planning
W2 to W3
Knowledge
Rewards
Costs
Action self-efficacy
Action planning

Coefficients (95 % CI)

P value

0.137(0.037, 0.237)
-0.006(-0.07, 0.058)
0.078(-0.028, 0.184)
0.277(0.120, 0.434)
0.344(0.168, 0.519)

0.007
0.847
0.147
0.001
<0.001

-0.002(-0.119, 0.115)
-0.043(-0.126, 0.041)
0.030(-0.071, 0.132)
0.057(-0.135, 0.249)
0.140(0.003, 0.277)

0.976
0.316
0.558
0.560
0.045

HIV disclosure stage transition matrix
The crude HIV disclosure stage transition matrix was shown in Figure 4.5. For
pre-intenders at W2, 76.0% stayed static between W2 to W3, 19.3% progressed to
intention, and 4.6% progressed to action. For intenders at W2, 57.8% stayed static
between W2 to W3, 30.2% regressed to pre-intention, and 12.0% progressed to action.
0.046

0.120

0.193
Intention
0.578

Pre-intention
0.760
0.302

Figure 4.5 HIV disclosure stage transition matrix
74

Action

Predictive effect of psychosocial factors on stage transition
Predictive effects of psychosocial factors at W2 on stage transition between W2
and W3 were shown in Table 4.8. The coefficients represent the effects of each
psychosocial factor on the log odds ratio of each specific transition pattern compared to
being static at W2 stage. Knowledge, perceived rewards, and perceived costs of parental
HIV disclosure at W2 were not predictive of stage transitions between W2 and W3.
Action self-efficacy increased the OR of progression from pre-intention to intention (OR
= 2.00, 95% CI 1.16, 3.47) compared to being static at pre-intention. Action planning
increased the OR of progression from pre-intention to intention (OR = 2.00, 95% CI 1.20,
3.37) and decreased the OR of regression from intention to pre-intention (OR = 0.43,
95% CI 0.18, 0.99). Details of stage-specific coefficients were summarized in Table 4.11.
Table 4.11 Predictive effects of psychosocial factors at W2 on stage transition between
W2 and W3 (odds ratio)

Knowledge
Rewards
Costs
Action selfefficacy
Action planning

Pre-intention
Pre-intention to Pre-intention
intention
to action
2.05, p = 0.16
1.49, p = 0.52
1.51, p = 0.42
1.92, p = 0.33
1.97, p = 0.23
0.54, p = 0.46
2.01, p = 0.013
1.99, p = 0.17

Intention
Intention to
Intention to
pre-intention
action
0.48, p = 0.12
13.6, p = 0.23
0.58, p = 0.33
4.85, p = 0.40
0.59, p = 0.33
72.2, p = 0.25
0.70, p = 0.20
0.38, p = 0.35

2.01, p = 0.008

0.43, p = 0.047

2.44, p = 0.12

2.12, p = 0.40

Discussion
Guided by the HAPA, this study tested the roles psychosocial factors play in the
theory-based parental HIV disclosure intervention. At 6-month after the intervention, a
statistically significant intervention effect was detected for disclosure knowledge, action
self-efficacy, and action planning but not for disclosure outcome expectancy. Stage75

specific predictive effects of action self-efficacy and action planning on HIV disclosure
stage transitions were detected.
Contrary to our hypothesis that the intervention will increase the rewards and
decrease the costs of parental HIV disclosure, no intervention effect was detected. One
major explanation is the measurement of outcome expectancy (Adams, Norman, Hovell,
Sallis, & Patrick, 2009). First, the “right” items generated by researchers can make
respondents aware of costs and rewards they may not have otherwise considered. Second,
participants’ initial inaccurate understanding of parental HIV disclosure (e.g., a one-time
“yes-no” event) may have already shifted to the more accurate “age-appropriate process”
proposed by our intervention. Therefore, the corresponding costs and rewards may relate
to different conceptualizations of HIV disclosure.
Among the four previous parental HIV disclosure interventions, two evaluated
intervention effects on psychosocial factors, especially disclosure self-efficacy (Conserve
et al., 2017). Similar to our findings, Murphy et al., found a statistically significant
improvement in disclosure self-efficacy 3 months after the intervention, which persisted
to 9 months (Murphy et al., 2011). Simoni et al. detected a significant improvement in
self-efficacy as soon as 4 weeks after the intervention, which persisted after 13 weeks
(Murphy et al., 2011). In terms of the measurement, the Simoni study measured selfefficacy with two items (how prepared/ready do you feel about making a decision on
whether, when, and how to disclose your HIV status to your child?’; and ‘How
prepared/ready do you feel about carrying out the decision you made on whether, when,
and how to disclose your HIV status to your child?’). The Murphy study measured selfefficacy with a 9-item scale which had high internal consistency (Cronbach’s alpha =
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0.90). Similar to the measure used in this study, participants’ confidence in deciding the
child’s developmental readiness, making an age-appropriate plan, conduct disclosure, as
well as deal with disclosure consequences (e.g., child’s emotional response, personal
questions on HIV) were measured. These results suggest that parental HIV disclosure
action self-efficacy can be improved within a relatively short time period.
Stage-specific predictive effects of psychosocial factors were found. Specifically,
motivational factors such as knowledge and outcome expectancy were not predictive of
stage transitions. Studies guided by the transtheoretical model have revealed that the total
pros scale reveals no significant differences between the Contemplation/Preparation
(corresponds to the intention stage) and Action/Maintenance (corresponds to the action
stage) stages (Kroll, Keller, Scholz, & Perren, 2011). More widely known as decisional
balance, outcome expectancy is a multidimensional construct with more than two broad
categories of pros and cons. The literature proposes four categories each for pros and
cons (gains/losses for self or significant others, self-approval/disapproval or
approval/disapproval from significant others) (Prochaska et al., 1994). Considering
analyzing the potential receiver is a key component in HIV disclosure, further research is
needed to distinguish the weighing of costs and rewards for parents themselves and the
children. Moreover, the decisional balance literature suggests that in terms of behavior
change, people not only weight the costs and rewards of the new behavior (i.e., HIV
disclosure), but also the old behavior (i.e., non-disclosure) (S. E. Collins, Carey, & Otto,
2009). Therefore, more complicated outcome expectancy measures are needed to capture
the multidimensionality of the construct.
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Previous studies proposed self-efficacy as a universal facilitator of stage
transitions as it predicts transitions between more than two stages (e.g., pre-intention to
action) and in both directions (i.e., progression and regression) (Schüz et al., 2008;
Schwarzer et al., 2007; Wiedemann et al., 2008). Our results suggest that the stagespecific action self-efficacy was only predictive of pre-intention to intention progression,
but not the progression from pre-intention to action. Moreover, action self-efficacy was
not preventive of stage regression from intention. One possible explanation, as supported
by a recent meta-analysis of studies applying the HAPA in health behavior contexts, was
that action self-efficacy is influential in intention formation but not intention violation
(Zhang, Zhang, Schwarzer, & Hagger, 2019). Also, as few people made the pre-intention
to action transition, our ability to detect the predictive effects were limited by the small
group size.
HAPA posits the importance of action planning for the translation of behavioral
intentions into behavior, not the formation of behavioral intentions. Our results indicate
that action planning facilitated pre-intention to intention progression and prevented the
intention to pre-intention regression. Therefore, participants in both the pre-intention and
the intention stages would benefit from action planning. Previous research on other health
behaviors showed that planning processes are important throughout all stages of change
(Armitage, 2006; Schüz, Sniehotta, Wiedemann, & Seemann, 2006; F F Sniehotta,
Araujo Soares, & Dombrowski, 2007). Another explanation is the difference between
action planning and coping planning. According to HAPA, action planning emphasizes
making when, where, and how plans while coping planning focuses on overcoming
obstacles by “anticipating personal risk situations (i.e. situations that endanger the
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performance of intended behavior)” (Sniehotta, Schwarzer, Scholz, & Schüz, 2005).
Given that parents face many barriers specifically in terms of the intention-to-action
translation, more research on the role of coping planning in promoting intention to action
transition is called for.
Several limitations exist in this study which may influence the interpretation of
our findings. First, we assumed no measurement error regarding HIV disclosure stage.
However, theoretically impossible backward stage transition out of the action stage was
observed in this study, suggesting potential misclassification bias. Second, due to the
measurement issue mentioned earlier, the outcome expectancy measures might not be
able to accurately capture participants’ perception of parental HIV disclosure as a
process. Third, child age has been identified as one of the most consistent and influential
predictor of parental HIV disclosure. However, we were unable to test whether stagespecific predictors differ by child age due to relatively low stage transition probabilities.
Despite these limitations, this study has significant implications for future studies.
First, the breakdown in the conceptual theory of the program in terms of outcome
expectancy indicates the need for further studies developing more accurate and complete
measures that capture the construct multidimensionality. Second, considering
psychosocial factors such as self-efficacy and planning predicted HIV disclosure stage
transition, the inclusion of such factors as intervention components is warranted. The
identification of such predictors also allows matching future interventions to
psychologically defined HIV disclosure stages (i.e., stage-specific interventions). Third,
as the traditional volitional psychosocial factors such as self-efficacy and planning were
found to influence intention formation but not intention translation, more studies are
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needed to examine psychosocial factors predicting intention to action progression.
Fourth, further attention should be paid to participants who made pre-intention to action
transition in terms of both study design (i.e., follow-up time interval) and data analysis
(i.e., collapsing with adjacent pre-intention to intention progression).
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CHAPTER 5
DISCUSSION AND CONCLUSION
5.1 SUMMARY OF THE DISSERTATION STUDY
Using three waves (baseline, 6-month, 12-month) of secondary longitudinal data
among 791 PLH participating an RCT of a theory-based parental HIV disclosure
intervention, this dissertation study evaluated intervention effects on parental HIV
disclosure process and disclosure-related psychosocial factors. Guided by the HAPA
model, the dissertation study focused on three objectives as below:
Study objective 1. This study adds to the literature of HIV disclosure by showing
that HIV disclosure can be operationalized as a process with 3 different stages: preintenders who don’t have disclosure intention, intenders who have disclosure intention
but haven’t disclosed, and actors who have disclosed. Using a multi-group first-order
Markov chain method, this study examined intervention effects on stage transition
between months 6 and 12. Results indicated that this theory-based intervention yielded
different effects for PLH at different initial stages of HIV disclosure. Specifically, preintenders responded most to the intervention while no statistically significant intervention
effect was detected for intenders.
Study objective 2. Using a proportional Latent Chang Score (LCS) method, this
study found a statistically significant intervention effect on disclosure knowledge, action
self-efficacy, and action planning as soon as 6 months after the intervention. Moreover,
the intervention kept improving disclosure action planning between 6 months and 12
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months follow-ups. However, no intervention effect was detected on outcome expectancy
measured by perceived costs and rewards of parental HIV disclosure.
Study objective 3. Traditional motivational factors such as knowledge and
outcome expectancy were not predictive of HIV stage transitions, while differential
effects of traditional volitional factors such as self-efficacy and planning were found for
pre-intenders and intenders. Action self-efficacy promoted pre-intention to intention
progression but did not prevent intention to pre-intention regression. Action planning
showed both a promoting effect on intention formation and a protective effect on
intention regression. No factor hypothesized in this study was found to influence the
intention to action transition.

5.2 INTERPRETATION OF STUDY FINDINGS
In terms of intervention effect on stage transition, our results suggested that the
intervention promoted progression from pre-intention to action, but not from preintention to intention. Intervention effect on such non-sequential stage transition can have
three possible explanations. First, as mentioned earlier, was the measurement error which
has the highest impact on the smallest response category (i.e., the pre-intenders) (Bassi et
al., 2000). Second, the intervention may promote pre-intenders to skip the intention stage
and go directly to the action stage within the 6 months (i.e., stage skipping). Third, the
intervention may promote a quicker sequential transition from pre-intention to intention
to action within 6 months. In terms of measurement error, more validation is needed to
come up with an accurate HIV disclosure stage measure. In addition, further studies
comparing the transition structure models with and without constraints on stage skipping
may help better understand whether such abrupt transition is possible. Finally,
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considering the follow-up window of 6 months may be too wide to capture the quick
transition, tighter follow-ups are needed to differentiate quick sequential transition from
stage skipping.
Regarding disclosure-related psychosocial factors, statistically significant
intervention effects were detected as early as the first follow-up at month 6. Lack of
intervention effect on outcome expectancy may be due to the measurement of such a
construct. First, the “right” items generated by researchers can make respondents aware
of costs and rewards they may not have otherwise considered. Second, outcome
expectancy is a multidimensional construct. Besides the two broad dimensions of costs
and rewards, whether such costs and rewards refer to oneself or significant others (in this
case, the child) should be considered. Recently, an outcome expectancy scale for partner
HIV disclosure identified five factors that were detected for both the costs and rewards
(Cao, Mo, & Lau, 2019). Moreover, the weighing of costs and rewards not only depends
on the targeted new behavior (i.e., disclosure) but also the old behavior (i.e., nondisclosure). The dimensionality of HIV disclosure outcome expectancy needs to be
examined and validated in further studies.

5.3 LIMITATIONS
Several limitations exist in this study which may influence the interpretation of
our findings. First, the item measuring HIV disclosure stage has not been validated
previously. Misclassification error may exist as theoretically impossible backward stage
transition out of the action stage was observed among more than half of participants
(64/119). Second, the literature suggests that outcome expectancy is a multidimensional
construct with four categories each for the costs and rewards (gains/losses for self or
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significant others, self-approval/disapproval or approval/disapproval from significant
others). Therefore, the two broad dimensions of costs and rewards may not fully capture
the multidimensionality. Third, child age has been identified as one of the most consistent
and influential predictor of parental HIV disclosure, both in terms of the likelihood of
disclosure and the depth. Due to relatively low stage transition probabilities for certain
patterns, we were not able to examine whether intervention effects, as well as stagespecific predictors, differ by child age group. Finally, process evaluation was not
conducted within this dissertation.

5.4 IMPLICATIONS
Despite these limitations, results from this dissertation study have significant
implications for future research. First, the inclusion of intermediate outcome variables in
the evaluation of HIV disclosure interventions which “aim more to diminish distress than
achieve a specific behavioral outcome” is warranted (Simoni et al., 2015). The inclusion
of such psychosocial factors not only enables us to capture the short-term intervention
effects but also helps elucidate how such intermediate outcome variables relate to more
distal outcomes (in this case, disclosure stage transition). as argued in HAPA, the
influence of psychosocial factors is stage-specific. However, as the stage transition can be
reversive (e.g., from pre-intention to intention, or from intention to pre-intention),
whether the psychosocial factors can influence both directions is not clarified. For
example, action self-efficacy is theoretically influential on intention formation, but
whether it can both promote pre-intention to intention progression and prevent intention
to pre-intention regression is not clear. Our results indicate that disclosure action selfefficacy may only promote disclosure intention formation, but not prevent intention
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regression. This suggests action self-efficacy may be beneficial only for the preintenders. Action planning, although theoretically influential only for intention
translation, was found to promote disclosure intention formation as well as prevent the
regression from intention to pre-intention. This suggests action planning can be beneficial
both for the pre-intenders and intenders.
Traditional stage-matched interventions guided by HAPA propose different
intervention components based on participants’ stages. Pre-intenders are assumed to
benefit more from motivational treatment focusing on risk communication, outcome
expectancies, and action self-efficacy. Intenders are assumed to benefit more from
volitional treatment focusing on coping self-efficacy, planning, and action control.
Regarding parental HIV disclosure, our results suggest that the inclusion of action
planning, a volitional treatment component usually addressed for intenders, may also
benefit the pre-intenders. The inclusion of action self-efficacy, a motivational treatment
component usually addressed for pre-intenders, may be needed only for the pre-intenders.

5.5 FUTURE DIRECTIONS
Future studies are needed for better measurement of HIV disclosure stage and
disclosure-related psychosocial factors. Moreover, the theoretical transition patterns of
HIV disclosure stage should be further examined. In addition, HIV disclosure stage is not
the endpoint of intervention evaluation. The evaluation of parental HIV disclosure
interventions may benefit from the consideration of the DPM embedded in the family
setting.
In terms of stage measurement, HIV disclosure was operationalized as a process
with 3 stages based on the HAPA model in this study. Finer-graded differentiations as,
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for example, in the TTM, which assumes 5 stages, can be meaningful with regard to the
differentiation of disclosure depth (e.g., partial vs. full) but have not been examined in
this study. Moreover, within the 3-stage HAPA, researchers suggested that planning
could be postulated as a moderator to further differentiate those who are at the intention
stage (Sutton, 2008). It is possible that planning can be set as another stage separate from
intention. Whether such finer-graded differentiations are meaningful for HIV disclosure
stage should be examined in further studies.
In terms of disclosure action self-efficacy, the social cognitive theory emphasizes
that it should be tailored to a specific behavior under specific conditions (Bandura, 1997).
Although we have considered specific tasks across the HIV disclosure process (e.g.,
deciding a child’s developmental readiness, making an age-appropriate plan, conduct
disclosure, as well as deal with disclosure consequences), the “condition” component was
not taken care of. As suggested by research regarding partner HIV disclosure, formative
elicitation studies are needed to derive realistic situations regarding disclosure
(Kalichman et al., 2001).
The social cognitive theory argued that a true stage model is comprised of an
ordered set of stages through which one must pass to reach the behavioral destination
(Bandura, 1994). Therefore, the skipping of stages is not theoretically allowed. However,
as one of the most widely used stage models, TTM assumes that stage transition can be
cyclical. Studies have found that individuals are most likely to skip the preparation stage
in TTM and try to move directly from contemplation into action (Britto et al., 2016;
Rodkjaer, Sodemann, Ostergaard, & Lomborg, 2011). As the HAPA is conceptualized as
a 2-stage or 3-stage model, limited research has been conducted to examine whether stage
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skipping is possible in HAPA. Most studies guided by HAPA have collapsed the
transition patterns into static, regression, and progression without differentiating the
adjacent stage transition from stage skipping (Zhang et al., 2019). Short-period followups in longitudinal studies and qualitative studies may further help elucidate whether
people move sequentially through the ordered stages within a short time or skip the
intention stage.
As argued in the DPM, besides the decision-making process, HIV disclosure
process also includes the outcome process through which the disclosure event influences
long-term individual (e.g., psychological and behavioral health), dyadic (e.g., intimacy
and trust), and social contextual (e.g., stigma) outcomes. Therefore, the disclosure event
should not be the endpoint of evaluation regarding parental HIV disclosure interventions.
Further evaluation needs to be conducted regarding whether and how the HIV disclosure
stage transition patterns influence both parents’ and children’s wellbeing, the dyadic
parent-child relationship and family functioning, as well as HIV-related stigma.
Finally, based on the family-based method, parental HIV disclosure happens in a
family setting rather than at the interpersonal level (i.e., between the HIV-positive parent
and the child) (Fisher & Weihs, 2000). Therefore, father-mother dyad also plays an
important role in parental HIV disclosure. Firdawsi et al. (2014) posited a socioecological model describing factors affecting parental HIV disclosure, where the
presence of and the relationship with the partner, the HIV status of partner, as well as
partner HIV disclosure, have been listed as key family-level components influencing
parental HIV disclosure (Firdawsi, 2014). Moreover, although parental HIV disclosure
was mostly led by the HIV-positive parent himself/herself, more studies viewing parental
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HIV disclosure at the family level are needed to shed light on what individuals (e.g.,
healthcare providers, the positive parent, another caregiver, another family member) or
teams (e.g., a parent-HCP team) can best convey parental HIV disclosure.

5.6 CONCLUSION
This dissertation study serves as a starting point of operationalizing HIV
disclosure as a process of 3-stages using the HAPA. Consistent with the HAPA, stagespecific intervention effects were detected. Action self-efficacy and action planning were
detected as two key psychosocial factors influencing HIV disclosure stage transition.
Further studies are needed to operationalize HIV disclosure stage under the guidance of
the DPM embedded in the family setting.
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APPENDIX A
SENSITIVITY ANALYSIS
As parameters involving between-level variables are not allowed to vary across
classes, the model treating c1 as a grouping variable cannot be used. Instead, intervention
was treated as a between-level categorical latent variable and used as a grouping variable
in data analysis. In the within part of the model, the random intercepts are shown in the
picture as filled circles at the end of the arrows pointing to c1 and c2. They were referred
to the cluster-level random effects as c1b and c2b (shown in the circles on the between
level). The random intercepts have no variance within the classes of the between-level
categorical latent variable “Intervention”. Individual-level factors were included as
within-level covariates influencing stage membership at W2.

C1

C2

Individual-level
covariates

Within

C1b

C2b

Between
Intervention

Figure A.1 Multilevel Markov chain model
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Results from the multilevel Markov Chain model were shown in Table A.1.
Marginally significant intervention effects were detected for stage transition from preintention to action compared to staying static at pre-intention.
Table A.1 Intervention effects on stage transition (multilevel model)

W2 stage
Pre-intention
Unadjusted model
Pre-intention Ref
Intention
0.70(0.30, 1.63)
Adjusted model
Pre-intention Ref
Intention
0.71(0.31, 1.62)

W3 stage
Intention

Action

Successful
transition

0.98(0.39, 2.47)
Ref

3.34(0.95, 11.68)
2.01(0.71, 5.70)

1.23(0.50, 3.02)
1.60(0.72, 3.55)

1.01(0.41, 2.53)
Ref

3.47(0.97, 12.38)
2.01(0.72, 5.61)

1.27(0.51, 3.13)
1.58(0.72, 3.49)

To model the intervention effect on psychosocial factors, a two-level latent
change score model was conducted (Figure A.2). In the within part of the model, the
filled circles at the end of the arrows from the within factors (M) to items. They represent
random intercepts that are referred to as items 1-3 in circles in the between part of the
model. In the between part of the model, the random intercepts are continuous latent
variables that vary across clusters represented by factors bM1 – bM3. Latent change
scores were also decomposed into within (LCS21 and LCS32) and between (bLCS21 and
bLCS32) levels. In this model, the residual variances of the factor indicators in the
between part of the model were fixed at zero. As the intervention was assigned to the
clinics, it was treated as a between-level variable. Individual-level factors such as
parents’ and children’s age and gender were included as within-level covariates
influencing M1.
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1
bM1

LCS32

Item2

Item1
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1

LCS21

Item3
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M3

β

1
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Covariates

Item1

1
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Item1

Item 3

Item3

Item1

Item2

Item3

1
bM3

bM2
1

β
bLCS21

1

β

bLCS32

Intervention

Figure A.2 Structural modeling setup for the multilevel proportional latent change score (LCS) model

Between

Intervention effects on psychosocial factors based on the multilevel proportional
LCS model were summarized in Table A.2. Noticeably, the multilevel model for action
planning failed to converge.
Table A.2 Intervention effects on psychosocial factors (multilevel model)

Coefficients (95 % CI)

P value

W1 to W2
Knowledge
Rewards
Costs
Action self-efficacy

0.141(0.04, 0.242)
-0.009(-0.077, 0.059)
0.089(-0.027, 0.206)
1.199(0.792, 1.606)

0.006
0.787
0.134
<0.001

W2 to W3
Knowledge
Rewards
Costs
Action self-efficacy

0.013(-0.097, 0.123)
-0.04(-0.114, 0.034)
0.053(-0.049, 0.155)
1.051(0.554, 1.548)

0.816
0.293
0.310
<0.001
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APPENDIX B
MPLUS CODES
TITLE:

MINPUT –Intervention effect on stage membership and stage transition

DATA: File = C:\Users\wendi\Dropbox\Dissertation\Proposal\LCA-3stg.csv;
VARIABLE:
NAMES ARE ID1 b c clinic status ageW1 A01W1 marital route cd4grp chdagegrp sex
ef1 ef2 ef3 r1 r2 r3 att1 att2 att3 difratio difeff difatt;
USEVARIABLES ARE ID1 b c clinic status
ageW1 female single divorce comsex blood other cd200 cd350 cd500
mid old girl ;
idvariable=ID1;
missing = all(-999);
CATEGORICAL ARE b c;
classes are cb(3) cc(3) ;
cluster=clinic;
define:
female = 0;
if (A01W1 eq 2) then female = 1;
single = 0;
if (marital eq 2) then single = 1;
divorce = 0;
if (marital eq 3) then divorce = 1;
comsex=0;
if (route eq 2) then comsex = 1;
blood=0;
if (route eq 3) then blood = 1;
other=0;
if (route eq 4) then other = 1;
cd200 = 0;
if (cd4grp eq 1) then cd200 = 1;
cd350 = 0;
if (cd4grp eq 2) then cd350 = 1;
cd500=0;
if (cd4grp eq 3) then cd500 = 1;
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mid=0;
if (chdagegrp eq 2) then mid = 1;
old=0;
if (chdagegrp eq 3) then old = 1;
girl = 0;
if (sex eq 2) then girl = 1;
CENTER ageW1 (GRANDMEAN);
ANALYSIS: TYPE = mixture complex;
ALGORITHM=INTEGRATION;
INTEGRATION=MONTECARLO;
STARTS = 400 40;
PROCESSORS = 2;
model:
%overall%
[cc#1@-15 cc#2@-15];
cc#1 on cb#1 (b11 );
cc#1 on cb#2 (b12 );
cc#2 on cb#1 (b21);
cc#2 on cb#2 (b22 );
cb on status ageW1 female mid old girl single divorce comsex blood other
cd200 cd350 cd500;
model cb:
%cb#1%
cc#1 on status (g11);
cc#2 on status (g21);
%cb#2%
cc#1 on status (g12);
cc#2 on status (g22);
%cb#3%
cc#1 on ;
cc#2 on ;
model cb:
%cb#1%
[b$1@15];
[b$2@20];
%cb#2%
[b$1@-15];
[b$2@15];
%cb#3%
[b$1@-20];

102

[b$2@-15];
model cc:
%cc#1%
[c$1@15];
[c$2@20];
%cc#2%
[c$1@-15];
[c$2@15];
%cc#3%
[c$1@-20];
[c$2@-15];
MODEL CONSTRAINT:
new(log11_x0 log12_x0 log21_x0 log22_x0
p11_x0 p12_x0 p13_x0
p21_x0 p22_x0 p23_x0
log11_x1 log12_x1 log21_x1 log22_x1
p11_x1 p12_x1 p13_x1
p21_x1 p22_x1 p23_x1
lo_fwd_12 lo_fwd_13 lo_fwd_1 lo_bwd_21 lo_fwd_23 lo_noback_2 );
!coefficients in the control group
log11_x0 = b11-15;
log12_x0 = b21-15;
log21_x0 = b12-15;
log22_x0 = b22-15;
p11_x0 = exp(log11_x0) / (exp(log11_x0) + exp(log12_x0) + 1);
p12_x0 = exp(log12_x0) / (exp(log11_x0) + exp(log12_x0) + 1);
p13_x0 = 1 / (exp(log11_x0) + exp(log12_x0) + 1);
p21_x0 = exp(log21_x0) / (exp(log21_x0) + exp(log22_x0) + 1);
p22_x0 = exp(log22_x0) / (exp(log21_x0) + exp(log22_x0) + 1);
p23_x0 = 1 / (exp(log21_x0) + exp(log22_x0) + 1);
!coefficients in the intervention group
log11_x1 = b11 + g11-15;
log12_x1 = b21 + g21-15;
log21_x1 = b12 + g12-15;
log22_x1 = b22 + g22-15;
p11_x1 = exp(log11_x1) / (exp(log11_x1) + exp(log12_x1) + 1);
p12_x1 = exp(log12_x1) / (exp(log11_x1) + exp(log12_x1) + 1);
p13_x1 = 1 / (exp(log11_x1) + exp(log12_x1) + 1);
p21_x1 = exp(log21_x1) / (exp(log21_x1) + exp(log22_x1) + 1);
p22_x1 = exp(log22_x1) / (exp(log21_x1) + exp(log22_x1) + 1);
p23_x1 = 1 / (exp(log21_x1) + exp(log22_x1) + 1);
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!log odds ratio comparing two groups
lo_fwd_12 = log((p12_x1 / p11_x1) / (p12_x0 / p11_x0));
lo_fwd_13 = log((p13_x1 / p11_x1) / (p13_x0 / p11_x0));
lo_fwd_1 = log(((1-p11_x1) / p11_x1) / ((1-p11_x0) / p11_x0));
lo_bwd_21 = log((p21_x1 / p22_x1) / (p21_x0 / p22_x0));
lo_fwd_23 = log((p23_x1 / p22_x1) / (p23_x0 / p22_x0));
lo_noback_2 = log(((p22_x1 + p23_x1) / p21_x1) / ((p22_x0 + p23_x0) / p21_x0));
OUTPUT: TECH1 TECH8 TECH10 TECH15 CINTERVAL;
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TITLE:

MINPUT –Intervention effect on psychosocial factors

DATA: File = C:\Users\wendi\Dropbox\Dissertation\Proposal\LCA-3stgitemsW3.csv;
VARIABLE:
NAMES ARE ID1 b c clinic status ageW1 A01W1 marital route cd4grp chdagegrp sex
ef1 ef2 ef3 r1 r2 r3 att1 att2 att3 difratio difeff difatt
Att_i1W1 Rew_i1W1 Rew_i2W1 Att_i2W1 Att_i3W1 Att_i4W1 Att_i5W1
Rew_i3W1 Rew_i4W1 Rew_i5W1 Cos_i1W1 Cos_i2W1 Cos_i3W1 Cos_i4W1
Eff_i1W1 Eff_i2W1 Eff_i3W1 Eff_i4W1 Eff_i5W1 Eff_i6W1 Eff_i7W1 Eff_i8W1
Eff_i9W1 Att_i1W2 Rew_i1W2 Rew_i2W2 Att_i2W2 Att_i3W2 Att_i4W2 Att_i5W2
Rew_i3W2 Rew_i4W2 Rew_i5W2 Cos_i1W2 Cos_i2W2 Cos_i3W2 Cos_i4W2
Eff_i1W2 Eff_i2W2 Eff_i3W2 Eff_i4W2 Eff_i5W2 Eff_i6W2 Eff_i7W2 Eff_i8W2
Eff_i9W2 Att_i1W3 Rew_i1W3Rew_i2W3 Att_i2W3 Att_i3W3 Att_i4W3 Att_i5W3
Rew_i3W3 Rew_i4W3 Rew_i5W3 Cos_i1W3 Cos_i2W3 Cos_i3W3 Cos_i4W3
Eff_i1W3 Eff_i2W3 Eff_i3W3 Eff_i4W3 Eff_i5W3 Eff_i6W3 Eff_i7W3 Eff_i8W3
Eff_i9W3;
USEVARIABLES ARE ID1 clinic status Att_- Att_i5W3 ageW1 female mid old girl;
idvariable=ID1;
missing = all(-999);
cluster=clinic;
DEFINE:
female = 0;
if (A01W1 eq 2) then female = 1;
mid=0;
if (chdagegrp eq 2) then mid = 1;
old=0;
if (chdagegrp eq 3) then old = 1;
girl = 0;
if (sex eq 2) then girl = 1;
CENTER ageW1 (GRANDMEAN);
ANALYSIS: TYPE = complex;
ALGORITHM=INTEGRATION;
INTEGRATION=MONTECARLO (10);
STARTS = 100 10;
PROCESSORS = 3;
MODEL:
att1 by Att_i1W1@1;
att1 by Att_i2W1 (1);
att1 by Att_i3W1 (2);
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att1 by Att_i4W1 (3);
att1 by Att_i5W1 (4);
att2 by Att_i1W2@1;
att2 by Att_i2W2 (1);
att2 by Att_i3W2 (2);
att2 by Att_i4W2 (3);
att2 by Att_i5W2 (4);
att3 by Att_i1W3@1;
att3 by Att_i2W3 (1);
att3 by Att_i3W3 (2);
att3 by Att_i4W3 (3);
att3 by Att_i5W3 (4);
Att_i1W1 with Att_i1W2 Att_i1W3 ;
Att_i2W1 with Att_i2W2 Att_i2W3 ;
Att_i3W1 with Att_i3W2 Att_i3W3;
Att_i4W1 with Att_i4W2 Att_i4W3;
Att_i5W1 with Att_i5W2 Att_i5W3;
Att_i1W3 with Att_i1W2;
Att_i2W3 with Att_i2W2;
Att_i3W3 with Att_i3W2;
Att_i4W3 with Att_i4W2;
Att_i5W3 with Att_i5W2;
[Att_i1W1@0];
[Att_i1W2@0];
[Att_i1W3@0];
[Att_i2W1@0];
[Att_i2W2@0];
[Att_i2W3@0];
[Att_i3W1@0];
[Att_i3W2@0];
[Att_i3W3@0];
[Att_i4W1@0];
[Att_i4W2@0];
[Att_i4W3@0];
[Att_i5W1@0];
[Att_i5W2@0];
[Att_i5W3@0];
att1 att2@0 att3@0;
[att1 att2@0 att3@0];
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!Diff score
difatt1 by att2@1;
difatt2 by att3@1;
!Autoregression
att2 ON att1@1;
att3 on att2@1;
!Proportional change
difatt1 on att1(b);
difatt2 on att2(b);
difatt1 on status;
difatt2 on status;
att1 with status;
OUTPUT: STDYX TECH1 SAMPSTAT SVALUES CINTERVAL;
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